Poster Listing
The poster presentation list is sorted by poster number then by poster session day (Tuesday or Wednesday). Please use the search function to locate presenter name, title, session, or poster presentation day. For additional sorting options click column headers.
Odd numbered posters presenters will present during Poster Session I on Tuesday, December 3, and Even numbered posters presenters will present during Poster Session II on Wednesday December 4. Please note that exceptions have been made for presenters with multiple posters to present on the same evening regardless of number.
To view poster display instructions and schedule for hanging and removing posters visit the Poster Presenter Tab.
Poster numbers and layout are final.
Tuesday
poster map
Wednesday
poster map
Click to view poster map
Click to view poster map
View Poster Session Floorplans
Poster Presentation Day | Poster Number | Poster Presenter | Organization | Submission ID | Topic | Abstract Title | Room | Abstract |
---|---|---|---|---|---|---|---|---|
TUES | 1 | Peter Mikhael | MIT | 59 | AI/ML-assisted Redesign of Native Proteins | CLIPZyme: Reaction-Conditioned Virtual Screening of Enzymes | Hall A | View Abstract |
WED | 2 | Doo Nam Kim | Pacific Northwest National Laboratory | 25 | AI/ML-assisted Redesign of Native Proteins | Computational Redesign of Monomeric Native Protein using Non-canonical Amino Acids | Hall A | View Abstract |
TUES | 3 | Leonie Windeln | University of Southampton | 444 | AI/ML-assisted Redesign of Native Proteins | De novo Design of alpha-Conotoxin Binding Proteins | Hall A | View Abstract |
TUES | 4 | Leonie Windeln | University of Southampton | 443 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | How do Autoencoders Help Explore the Conformational Space of MD Simulations of Cyclic Peptides? | Hall A | View Abstract |
WED | 6 | Jerome Alvarez | Naval Research Laboratory | 29 | AI/ML-assisted Redesign of Native Proteins | TEMPRO: nanobody melting temperature estimation model using protein embeddings | Hall A | View Abstract |
TUES | 7 | Jorge Chavez | Air Force Research Laboratory | 115 | AI-powered Diagnostics | A closed-loop Wearable Platform for Synthetic Biology-powered Sensing and Delivery of Interventions | Hall A | View Abstract |
WED | 8 | Lyman Monroe | Los Alamos National Laboratory | 674 | AI-powered Diagnostics | A new software for conotoxin identification and classification | Hall A | View Abstract |
TUES | 9 | Armand Paauw | Netherlands Organization for Applied Scientific Research TNO, Department of CBRN Protection, The Netherlands | 195 | AI-powered Diagnostics | A proteomics-approach for Biological Threat Agents Detection and Identification | Hall A | View Abstract |
WED | 10 | Jamie Inman | LBNL | 418 | AI-powered Diagnostics | A Reagent-free Portable Biosensor for Spectral Detection of biologically active molecules | Hall A | View Abstract |
TUES | 11 | Patrick Chain | Los Alamos National Laboratory | 728 | AI-powered Diagnostics | A Sequence-based Pathogen-Agnostic Detection/Diagnostics Solution | Hall A | View Abstract |
WED | 12 | Markus Antwerpen | Bundeswehr Institute of Microbiology | 432 | AI-powered Diagnostics | Development of an automated system for the analysis of large-scale patient care records | Hall A | View Abstract |
WED | 14 | Kaitlyn Martinez | Los Alamos National Laboratory | 596 | AI-powered Diagnostics | Factors Influencing Accuracy, Interpretability, and Reproducibility in the use of Machine Learning in Biology | Hall A | View Abstract |
TUES | 15 | Mark Maupin | PNNL | 117 | AI-powered Diagnostics | Finch: An AI-Powered Toolbox for the Prediction of Chemical Mixture's Physiological Function and Hazard Profile | Hall A | View Abstract |
WED | 16 | Daniel Jacobsen | Los Alamos National Laboratory | 578 | AI-powered Diagnostics | Innate Immune System Based Distinction of Gram-Positive and Gram-Negative Bacteria | Hall A | View Abstract |
TUES | 17 | Apoorv Shanker | Los Alamos National Laboratory | 533 | AI-powered Diagnostics | Innate immune signatures of viral exposure in lung epithelial cells | Hall A | View Abstract |
WED | 18 | Wenting Shao | University of Pittsburgh | 610 | AI-powered Diagnostics | Machine Learning Discrimination and Ultrasensitive Detection of Fentanyl Using Gold Nanoparticle-Decorated Carbon Nanotube-Based Field-Effect Transistor Sensors | Hall A | View Abstract |
TUES | 19 | Anders Wallqvist | U.S. Army Medical Research and Development Command | 112 | AI-powered Diagnostics | Mining public genomics data identifies potential kidney injury biomarkers | Hall A | View Abstract |
TUES | 20 | Anders Wallqvist | U.S. Army Medical Research and Development Command | 110 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Toxidrome screening: AI-based safety assessment of chemicals | Hall A | View Abstract |
TUES | 21 | Anders Wallqvist | U.S. Army Medical Research and Development Command | 113 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Can AI-based models serve as an alternative to experimental high-throughput screening? | Hall A | View Abstract |
TUES | 22 | Anders Wallqvist | U.S. Army Medical Research and Development Command | 111 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | AI applications for assessing safety profiles of chemicals and drugs | Hall A | View Abstract |
TUES | 23 | Krista Ternus | Signature Science, LLC | 435 | AI-powered Diagnostics | Predicting sequences of concern with machine learning | Hall A | View Abstract |
WED | 24 | Lisa Bramer | Pacific Northwest National Laboratory | 352 | AI-powered Diagnostics | Profiling Healthy Human Breath using Artificial Intelligence | Hall A | View Abstract |
TUES | 25 | Megan Guetzloff | Teledyne FLIR Defense | 304 | AI-powered Diagnostics | Rapid detection and classification of fentanyl analogs by 2D MS/MS coupled with a novel library-less machine learning algorithm | Hall A | View Abstract |
WED | 26 | Jason Gans | Los Alamos National Laboratory | 322 | AI-powered Diagnostics | Recent progress towards rapid, automated design of nucleic acid-based pathogen diagnostic assays | Hall A | View Abstract |
WED | 27 | Jason Gans | Los Alamos National Laboratory | 326 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Enabling the rapid search of petabyte-scale DNA sequence databases with Bloom filters | Hall A | View Abstract |
WED | 28 | Andrew Matas | Battelle Memorial Institute | 332 | AI-powered Diagnostics | Self-attention feature fusion: A platform for multimodal biomedical AI | Hall A | View Abstract |
TUES | 29 | Jacob Beal | RTX BBN | 540 | AI-powered Diagnostics | Tactical Bioinformatics with Secure Bloom-Filter Analysis and Compression (SB-FAC) | Hall A | View Abstract |
WED | 30 | Jane Preston | King's College London | 196 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | A syngenic porcine in vitro blood-brain barrier model predicts in vivo brain delivery of therapeutic antibodies. | Hall A | View Abstract |
TUES | 31 | Aidan Tran | United States Military Academy | 134 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Bacteriophage Therapy Rescues Caenorhabditis elegans from Pseudomonas aeruginosa Infection and Preserves the Gut Microbiome | Hall A | View Abstract |
WED | 32 | Benjamin Wadsworth | United States Army Medical Research Institute of Chemical Defense | 618 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Characterization of a humanized mouse model of organophosphate nerve agent poisoning and detection of countermeasures via MALDI-MSI. | Hall A | View Abstract |
TUES | 33 | Christopher Cote | United States Army Medical Research Institute of Infectious Diseases (USAMRIID) | 146 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Characterization of virulence of the Burkholderia pseudomallei ATS2021 strain isolated from aromatherapy spray unintentionally imported to the United States from India | Hall A | View Abstract |
WED | 34 | Michael Barrera | George Mason University | 353 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | The New World Alphavirus Inhibitor Bardoxolone Methyl Affects Host Kinases And Impacts Nonstructural Protein Production | Hall A | View Abstract |
WED | 35 | Michael Barrera | George Mason University | 347 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Novel inhibitors of the alphavirus nsP2 protease demonstrate protection in an organ-on-a-chip model of the blood-brain barrier and in an in vivo model | Hall A | View Abstract |
TUES | 36 | Sara Ruiz | USAMRIID | 703 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Development of a Neurological Melioidosis Model | Hall A | View Abstract |
TUES | 37 | Sara Ruiz | USAMRIID | 701 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Impact of Co-infection on Disease Progression | Hall A | View Abstract |
WED | 38 | J. Matthew Meinig | Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases | 376 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Establishing PK/PD drivers of therapeutic efficacy for bacterial threats: bridging in vitro and in vivo results using neutropenic mouse and hollow-fibre infection models | Hall A | View Abstract |
TUES | 39 | Justin Sherlock | USAMRICD | 341 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Evaluating airway responsiveness: leveraging a novel assay for assessing functional response in precision-cut lung slices (PCLS) from a humanized mouse model | Hall A | View Abstract |
WED | 40 | Christina Burrows | USAMRIID | 294 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Evaluation of host response to neurological infection with Burkholderia pseudomallei ATS2021 strain in C57BL/6 mice | Hall A | View Abstract |
TUES | 41 | Olivia Bellek | USAMRICD | 349 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Exploring the effects of in utero acute organophosphorus nerve agent (OPNA) exposure on mouse behavior | Hall A | View Abstract |
WED | 42 | Seraiah Coe | MRICD | 565 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Identifying epimutation inheritance following acute maternal organophosphorus nerve agent (OPNA) exposure | Hall A | View Abstract |
TUES | 43 | John Dye | USAMRIID | 23 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Marburg Virus Disease in Cynomolgus Monkeys for Development of Therapeutics | Hall A | View Abstract |
WED | 44 | Michael Davies | USAMRIID | 263 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Sex Differences in Protection Conferred by Heterologous Vaccines for Pneumonic Plague in an Aerosol Challenge Model | Hall A | View Abstract |
WED | 46 | Colin Bishop | WFIRM | 75 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Use of Animal OTEs to Determine the Appropriate Model Species for MCM Development | Hall A | View Abstract |
TUES | 47 | SE HUN GU | Agency for Defense Development | 298 | CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails | Viral infection and antiviral drug efficacy evaluation using organoids platform | Hall A | View Abstract |
WED | 48 | Anuj (AJ) Singhal | CFD Research | 684 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | 7-Day Prophylactic Antiviral Patch with Host-Based MOA and Broad Spectrum Protection | Hall A | View Abstract |
TUES | 49 | Lidimarie Trujillo Rodriguez | DTRA | 309 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A healthy human microbiome-informed method for enhancing in silico predictions of therapeutic phage safety | Hall A | View Abstract |
TUES | 51 | Dominique Hall | Lawrence Livermore National Laboratory, Livermore | 410 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A Nanolipoprotein Particle Platform Vaccine Targeting Ebola Virus Elicits a Robust Immune Response In Vivo | Hall A | View Abstract |
TUES | 53 | Cherise Ang | Recce Pharmaceuticals Ltd | 404 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A Novel Broad-Spectrum Rapid Response To MDR Bacterial Threats | Hall A | View Abstract |
WED | 54 | Allyson Hirsch | Tulane University | 262 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A novel OMV adjuvant, T-vant, enhances the efficacy of the acellular pertussis vaccine | Hall A | View Abstract |
WED | 56 | Kumkum Ganguly | Los Alamos National Laboratory | 580 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A Tetra-cell Blood-Brain Barrier (BBB) Model System for High Throughput Screening of Medical Countermeasures (MCMs) for Rapid Response | Hall A | View Abstract |
TUES | 57 | Apichai Tuanyok | University of Florida | 215 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Advanced Phage-Based Strategies for Biodefense Against Burkholderia pseudomallei | Hall A | View Abstract |
WED | 58 | Sophie Walker | Kimer Med Limited | 138 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Advancing Rapid Countermeasures Against Viral Threats with the VTose® Antiviral Platform | Hall A | View Abstract |
TUES | 59 | Steven Branda | Sandia National Laboratories | 412 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Airway microbiome manipulation to counter respiratory infection | Hall A | View Abstract |
WED | 60 | Thomas Laws | DSTL | 68 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | An anti-inflammatory treatment strategy to ameliorate the pathogenic effects of Venezuelan Equine Encephalitis Virus infection. | Hall A | View Abstract |
TUES | 61 | Jennifer Schwedler | Sandia National Labs | 193 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | An Anti-VEEV BBB-penetrating bispecific provides comparable therapeutic protection in the context of VEEV-TrD infection in vivo | Hall A | View Abstract |
WED | 62 | Rekha Panchal | USAMRIID | 116 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Antiviral activity of Opaganib, a first-in-class sphingolipid modulator | Hall A | View Abstract |
TUES | 63 | Matthew Coleman | Lawrence Livermore National Laboratory | 715 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Apolipoprotein-nanodisc as a novel tool for solubilization and delivery of medical countermeasures. | Hall A | View Abstract |
WED | 64 | Carl Gelhaus | Appili Therapeutics USA Inc | 450 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | ATI-1701: Ongoing Development of a Live Attenuated Tularemia Vaccine Based on a SCHU S4 ΔclpB Mutant | Hall A | View Abstract |
WED | 66 | Christina Gardner | U.S. Army Medical Research Institute of Infectious Diseases | 598 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Bivalent VHH antibodies are protective against lethal Venezuelan equine encephalitis challenge in mice | Hall A | View Abstract |
TUES | 67 | Katherine Besse | MIT Lincoln Laboratory | 163 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Building innate warfighter resiliency against CB threats via the gut microbiome | Hall A | View Abstract |
WED | 69 | Oscar Negrete | Sandia National Laboratories | 434 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A lipid nanoparticle mRNA vaccine expressing Ebola virus glycoprotein elicits strong immunological response and protection against challenge with a VSV-ZEBOVgp model of ZEBOV infection | Hall A | View Abstract |
WED | 70 | Olivia Pimentel | Los Alamos National Laboratories | 497 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Characterization of bacterial lipid nanodiscs as potential vaccine candidates | Hall A | View Abstract |
TUES | 71 | Sharon Jan | Sandia National Laboratories | 187 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Characterization of iron homeostasis during New World Arenavirus infection for therapeutic drug design | Hall A | View Abstract |
WED | 72 | Morgen VanderGiessen | Virginia Tech | 399 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Characterization of Neurological Sequelae Induced by Venezuelan Equine Encephalitis Virus | Hall A | View Abstract |
TUES | 73 | Vladislav Sandler | Hemogenyx Pharmaceuticals | 46 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Chimeric Bait Receptor (CBR) for Reprogramming of Myeloid Cells to Target and Eliminate Emerging Viral Infections | Hall A | View Abstract |
WED | 74 | Conor Jenkins | U.S. Army DEVCOM Chemical Biological Center | 207 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Comparing cost & efficacy of antibody sequencing techniques | Hall A | View Abstract |
TUES | 75 | Diane Jamrog | MIT Lincoln Laboratory | 10 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Computational Model to Assess Medical Countermeasures for Dengue Fever | Hall A | View Abstract |
WED | 76 | Chad Testa | Curza, Inc | 459 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | CZ-02188 is a New Class of Antibacterial Agent, with a New Mechanism-of-action to Mitigate Multidrug-resistant Pathogens, Including Tier 1 Select Agents, with Efficacy in Mouse Models of Infection and Safety in Multiple Animal Species | Hall A | View Abstract |
WED | 78 | Nileena Velappan | Los Alamos National Laboratory | 260 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Developing Nanofiber-Based Engineered Platforms for Enhanced Armed Forces Health and Biosecurity | Hall A | View Abstract |
WED | 79 | Nileena Velappan | Los Alamos National Laboratory | 449 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Nanobody Engineering for Novel Diagnostics | Hall A | View Abstract |
WED | 80 | Kiran Sewsankar | Applied Research Associates, Inc. | 619 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Development of a mathematical model of within-host dynamics of illness following biological agent exposure | Hall A | View Abstract |
TUES | 81 | Jeff Hutchins | Inhalon Biopharma | 559 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Development of an inhaled broadly neutralizing antibody treatment for seasonal and pandemic influenza A | Hall A | View Abstract |
WED | 82 | Puttawat Suphaprueksapong | University of Florida | 635 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Development of mRNA-Based Biologics Targeting PD-1 for Enhanced Melioidosis Management | Hall A | View Abstract |
TUES | 83 | Chiho Yu | Agency for Defense Development | 55 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Development of Rapid Therapeutics Platform Against Emerging Infectious Virus | Hall A | View Abstract |
WED | 84 | Cherry Gupta | Battelle Memorial Institute | 742 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | DNA origami nanostructures for effective targeted intracellular delivery of small molecule drugs. | Hall A | View Abstract |
TUES | 85 | Caitlin Woodson | Virginia Tech | 553 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | EGR1 influences neuropathology in mice following infection with Venezuelan equine encephalitis virus (VEEV) in a sex-dependent manner | Hall A | View Abstract |
WED | 86 | Steven Hoang-Phou | Lawrence Livermore National Laboratory | 695 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Encapsulation for supporting in situ cell-free generation and release of vaccine antigens | Hall A | View Abstract |
TUES | 87 | Marie Kim | University of Chicago | 354 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Enhanced innate recruitment and functionality after small molecule training as prophylactic for Listeria monocytogenes | Hall A | View Abstract |
WED | 88 | HongSeok Choi | ABION Inc., Republic of Korea | 8 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Enhancing DNA Vaccine Delivery Through Microneedle Patch Technology with Low-Voltage Electroporation | Hall A | View Abstract |
TUES | 89 | Wei He | Lawrence Livermore National Laboratory | 379 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Evaluating mRNA-Based Vaccines Against Burkholderia pseudomallei Infection | Hall A | View Abstract |
WED | 90 | Matthew Seavey | Elusys Therapeutics, Inc. | 22 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Evaluation of Immunogenicity and Efficacy of a Novel, Live Attenuated Anthrax Spore Vaccine, ‘LAV-BASTA-48’, for Postexposure Prophylaxis (PEP) | Hall A | View Abstract |
TUES | 91 | Jason Ladner | Northern Arizona University | 378 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | High resolution antibody profiles for evaluating vaccine platforms and identifying antigens | Hall A | View Abstract |
WED | 92 | Hannah Riley Knight | University of Chicago | 53 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | High Throughput Screen for Novel Small Molecule Inducers of Trained Immunity | Hall A | View Abstract |
TUES | 93 | Allison Yorita | Lawrence Livermore National Laboratory | 706 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Host-directed, bioelectronic immunomodulation for protection against emerging pathogens | Hall A | View Abstract |
WED | 96 | Jason Blackburn | University of Florida | 268 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Vaccine Efficacy Against Antigenically Novel Anthrax Causing Pathogens | Hall A | View Abstract |
TUES | 97 | Stephanie Monticelli | Virology Division, U.S. Army Medical Research Institute of Infectious Diseases/The Geneva Foundation | 139 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Human derived monoclonal antibodies are protective against lethal Machupo virus challenge in guinea pigs | Hall A | View Abstract |
WED | 98 | Lillian Chiang | Evrys Bio LLC | 550 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Human sirtuin-2 protein (SIRT2) - a host-target providing broad-spectrum effectiveness through multiple mechanisms of viral restriction and immunity | Hall A | View Abstract |
TUES | 99 | Joshua Breidenbach | Biochemistry and Biotechnology Group, Bioscience Division, Los Alamos National Laboratory | 730 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Identification of countermeasures against viral replication by targeting viral entry-related host proteins | Hall A | View Abstract |
WED | 100 | Christopher Sumner | Sandia National Laboratory | 390 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Identification of host-targeting nanobodies disrupting new-world arenavirus receptor binding | Hall A | View Abstract |
TUES | 101 | Carol Anderson | George Mason University | 35 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Identification of Verteporfin and Protoporphyrin IX via medium throughput, in vitro screen where they act as robust, broad-spectrum inhibitors of emerging arthropod viruses. | Hall A | View Abstract |
TUES | 103 | Michael Wannemuehler | Iowa State University | 521 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Impact of gut microbial complexity on the host response to vaccination against A viral pathogen | Hall A | View Abstract |
WED | 104 | Joel Bozue | USARMIID | 51 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Implementation of a Post-Exposure Tularemia Treatment Model for Pneumonic Challenged Fischer Rats | Hall A | View Abstract |
TUES | 105 | Spencer Stonier | Emergent BioSolutions | 237 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Integrated, Rapid Antibody Discovery and Cell Line Development to Truncate Timelines for Manufacturing Teadiness | Hall A | View Abstract |
TUES | 107 | Lindsey Anderson | Pacific Northwest National Lab | 426 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | KESTREL: Knowledge Extraction for Strategic Threat Response using Evidence from the Literature | Hall A | View Abstract |
WED | 108 | Jon Snedeker | Lactea Therapeutics | 320 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Limiting biothreat exposure with a novel purified bioactive lactoferrin as a multifunctional countermeasure in battlefield wounds | Hall A | View Abstract |
TUES | 109 | David Saunders | Uniformed Services University School of Medicine | 121 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Live-Attenuated, Rearranged V4020 Vaccine for Venezuelan Equine Encephalitis: Preclinical Studies | Hall A | View Abstract |
WED | 110 | Mahgol Behnia | UNIVERSITY of New Mexico | 534 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | lncRNA Snhg15 positively regulates inflammatory response to Venezuelan equine encephalitis virus infection in primary mouse astrocytes | Hall A | View Abstract |
TUES | 111 | Lindsay Odell | U.S. Department of Health and Human Services, Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority | 241 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Mitigating Severe Outcomes of Disease Caused by Emerging Threats | Hall A | View Abstract |
WED | 112 | Ruy Ribeiro | Los Alamos National Laboratory | 270 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Modeling the generation of vaccine-induced antibodies from multiple vaccine platforms | Hall A | View Abstract |
TUES | 113 | Jason Thornton | University of Florida College of Veterinary Medicine Department of Infectious Diseases and Immunology | 468 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Multivalent Outer Membrane Vesicle (OMV) Vaccine for Melioidosis and Glanders Disease | Hall A | View Abstract |
WED | 114 | Riccardo D'Elia | DSTL | 288 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Non-ionic surfactant vesicles (NISV) have host directed therapeutic potential and can be targeted to the brain | Hall A | View Abstract |
TUES | 115 | Xiaoqiong Xia | University of Pennsylvania | 608 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Nonnegative matrix factorization approach to identify host-pathogen interactions and develop medical countermeasures to stem outbreaks | Hall A | View Abstract |
TUES | 116 | James Collins | MIT | 269 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | A Generative Deep Learning Approach to de novo Antibiotic Design | Hall A | View Abstract |
TUES | 117 | Adam Taylor | Dstl | 303 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Novel antibody based therapies have the potential to improve medical countermeasures for pathogens of defense concern. | Hall A | View Abstract |
WED | 118 | Xiaofang Huang | Emergex USA | 391 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development | Hall A | View Abstract |
TUES | 119 | Haseebullah Baha | School of Systems Biology, College of Science, George Mason University | 769 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | NRF2 signaling as a central, broad-spectrum host defense and response strategy against (re)emerging viral pathogens | Hall A | View Abstract |
WED | 120 | Niloufar A. Boghdeh | School of Systems Biology, College of Science, George Mason University | 421 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Omaveloxolone as a broad-spectrum intervention strategy against vector transmitted RNA viruses | Hall A | View Abstract |
WED | 122 | Bahman Asgharian | Applied Research Associates, inc. | 344 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Optimizing Drug Delivery to the Respiratory Tract Using in silico Models | Hall A | View Abstract |
TUES | 123 | Evan Lloyd | The Johns Hopkins University Applied Physics Laboratory | 741 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Penems: Orally Available, Shelf Stable, Broad Spectrum Antibiotics | Hall A | View Abstract |
TUES | 125 | Paul Phillips | Northern Arizona University | 532 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Potential vaccine correlates of protection: Evaluation of B cell and T cell receptors generated using different vaccine platforms. | Hall A | View Abstract |
TUES | 126 | Erik Settles | Northern Arizona University | 474 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Validation of OMV vaccine composition through immune reactivity and mass spectrometry to generate assays for manufacturing and clinical trials | Hall A | View Abstract |
TUES | 127 | Gavin Morrow | IAVI | 333 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Protective Vaccination of Nonhuman Primates against Aerosol Exposure to Marburg Virus using a Vesicular Stomatitis Virus-vectored Vaccine – Implications for Mucosal Vaccine Strategies and Unpredictable Filovirus Transmission | Hall A | View Abstract |
WED | 128 | Ruy Ribeiro | Los Alamos National Laboratory | 478 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Quantification of human heterogeneity in CD8+ T cell responses: immune correlates of protection | Hall A | View Abstract |
TUES | 129 | Jessica Kubicek-Sutherland | Los Alamos National Laboratory | 94 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Rapid Assessment of Platform Technologies to Expedite Response (RAPTER) | Hall A | View Abstract |
WED | 130 | Taehyung Kwon | Los Alamos National Laboratory | 582 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Rapid Detection of Viral Infection With Host Epitranscriptional Signatures | Hall A | View Abstract |
TUES | 131 | Bin Hu | Los Alamos National Laboratory | 233 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | An Automated 10x scRNA-seq Workflow | Hall A | View Abstract |
TUES | 132 | Bin Hu | Los Alamos National Laboratory | 71 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Learning the Language of Proteins | Hall A | View Abstract |
TUES | 133 | Madeline Bolding | Los Alamos National Laboratory | 554 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Lipid targeting for select agent countermeasures | Hall A | View Abstract |
TUES | 135 | Xiankun (Kevin) Zeng | USAMRIID | 245 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Sudan Virus Persists in the Immune Privileged Organs of Nonhuman Primate Survivors | Hall A | View Abstract |
WED | 136 | Monique van Hoek | George Mason University | 636 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Sustained delivery of Vancomycin over time using QuickGel Click Hydrogel for the treatment of surgical site infections | Hall A | View Abstract |
WED | 137 | Monique van Hoek | George Mason University | 482 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Coupling hemolysis predictor algorithms with real-world data for a defibrinated human blood hemolysis assay for the development of novel antimicrobial peptide therapeutics to target MDROs. | Hall A | View Abstract |
WED | 138 | Monique van Hoek | George Mason University | 488 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Cell-penetrating peptide predictors to design delivery vehicles for morpholinos and peptide-nucleic acids to Pseudomonas aeruginosa. | Hall A | View Abstract |
TUES | 139 | Joey Shi | United States Military Academy | 699 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Synergistic effects of novel phage cocktails with carbapenem antibiotics against multi-drug resistant Pseudomonas aeruginosa as a layered medical countermeasure | Hall A | View Abstract |
WED | 140 | Nicholas Hum | Lawrence Livermore National Laboratory | 711 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Targeting SPP1-positive Macrophages for Therapeutic Intervention in Pulmonary Infection | Hall A | View Abstract |
WED | 142 | Robert Lavieri | Quantum Leap Healthcare Collaborative | 427 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | I-SPY ARDS Platform Clinical Trial: Demonstrating a Rapid Response Capability for Emerging Respiratory Threats | Hall A | View Abstract |
WED | 144 | Harold Kim | Vasomune Therapeutics Inc. | 594 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | A Randomized, Double-blind, Placebo-controlled Phase 1 Single and Multiple-dose Pharmacokinetic First-in-Human Study of AV-001 in Healthy Subjects for the Treatment of Acute Respiratory Distress Syndrome | Hall A | View Abstract |
TUES | 145 | Hiroyuki Nakashima | National Defense Medical College | 87 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Training the innate immune system with low-dose endotoxin provides broad defense against bacteria-induced sepsis | Hall A | View Abstract |
WED | 146 | Christian Xander | USAMRIID | 84 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Treatment of bacterial biothreat agents with a novel purified bioactive bovine lactoferrin as a medical countermeasure | Hall A | View Abstract |
TUES | 147 | Sanskruthi Sreepangi | George Mason University | 464 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Ubiquitin E3 ligases as therapeutic targets towards achieving broad-spectrum inhibition of vector-transmitted, neurotropic viruses. | Hall A | View Abstract |
WED | 148 | Kevin Mlynek | USAMRIID | 82 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Understanding natural variation of LPS to promote attenuation in Francisella tularensis | Hall A | View Abstract |
TUES | 149 | Sarah Harrison | The Johns Hopkins University, Applied Physics Laboratory | 231 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Understanding the mechanisms of high-level ciprofloxacin resistance in Bacillus cereus sensu lato group of bacteria | Hall A | View Abstract |
WED | 150 | Aidan Epstein | Lawrence Livermore National Lab | 751 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Vaccine Ranking Analysis Framework | Hall A | View Abstract |
TUES | 151 | Sergei Biryukov | USAMRIID | 100 | Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response | Yersinia Pestis NLP subunit vaccine platform: Protective efficacy and immunological profile | Hall A | View Abstract |
WED | 152 | Patrick McNutt | Wake Forest University Health Sciences | 614 | Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing | Applying machine learning to human microphysiological systems to predict infection and virulence for new and emerging viruses | Hall A | View Abstract |
WED | 154 | Jeff Borenstein | Draper Lab | 676 | Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing | Bioinspired microfluidic design of coagulation-free blood perfusion systems | Hall A | View Abstract |
TUES | 155 | Tyler Goralski | U.S. Army DEVCOM Chemical Biological Center | 52 | Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again | Biological Risk Evaluation and Threat Hazard Effects (BREATHE) | Hall A | View Abstract |
TUES | 156 | Desiree Harris | Precise Systems | 228 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Understanding Mixtures: Assessing Chemical Compound Mixtures for Toxicological Characterization | Hall A | View Abstract |
TUES | 157 | Priscilla Lee | U.S. Army DEVCOM Chemical Biological Center | 225 | Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing | Incorporation of Immune Response into Organ-on-a-Chip Technology (CASCADE) | Hall A | View Abstract |
WED | 158 | Sarah Grady | Johns Hopkins University Applied Physics Laboratory | 644 | Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing | Immunity Twin: Utilizing mechanistic modeling and ML-informed image analysis to develop actionable medical interventions for challenges to human lung | Hall A | View Abstract |
WED | 162 | Mattheus Ueckermann | Creare LLC | 69 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | 3-D reconstruction, visualization, and modeling of buildings from multiple image sources | Hall A | View Abstract |
TUES | 165 | Robert Schwieterman | Teledyne FLIR | 515 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | Digital Battlefield CB Threat Mapping and Augmented Reality Display | Hall A | View Abstract |
WED | 166 | Lance McLean | Noblis ESI | 675 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | Extended Reality for Chemical, Biological, Radiological, and Nuclear (CBRN) Training | Hall A | View Abstract |
TUES | 167 | Tim Lawton | U.S. Army - DEVCOM Soldier Center | 366 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | Integrated Multi-Threat Headborne System (IMHS) – Heads-up Display for Enhanced CBRN Situational Awareness | Hall A | View Abstract |
WED | 168 | Donovan Quimby | Aeris, LLC | 523 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | Structurally Consistent Rapid Internal Building Estimation (SCRIBE) | Hall A | View Abstract |
TUES | 169 | Ashley McGuirk | Applied Research Associates, Inc. | 507 | eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation | Using Virtual Reality to Explore Operational Utility, Virtual and Digital Twins for CBRN Situational Awareness | Hall A | View Abstract |
WED | 170 | Samir Deshpande | U.S. Army DEVCOM Chemical Biological Center | 463 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | : Near real-time analysis of long reads for detection of organisms using MinION sequencer | Hall A | View Abstract |
TUES | 171 | Cassie Bryan | Draper Lab | 671 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | A comprehensive bioinformatics pipeline for the identification of conserved binding sites enables broad-spectrum biological threat detection and MCM development | Hall A | View Abstract |
WED | 172 | Aditi Naik | Draper Lab | 498 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | A fieldable system for automated nucleic acid extraction | Hall A | View Abstract |
TUES | 173 | Daniel Phillips | U.S. Army DEVCOM Chemical Biological Center | 252 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | A field-reprogrammable toxin detection platform | Hall A | View Abstract |
WED | 174 | Kjiersten Fagnan | Lawrence Berkeley National Laboratory | 396 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | A framework for standardization of multi-omics data streams between the DOE Joint Genome Institute and National Microbiome Data Collaborative to support FAIR data generation | Hall A | View Abstract |
TUES | 175 | Angela Zeigler | U.S. Army DEVCOM Chemical Biological Center | 323 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | ABACUS- Autonomous BioAerosol Collection for Universal Sampling | Hall A | View Abstract |
WED | 176 | Tilly Lawrence | Leidos | 526 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Acceleration of clinical trials under pandemic conditions: lessons learned | Hall A | View Abstract |
WED | 177 | Tilly Lawrence | Leidos | 530 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | The synergistic observational research community of tomorrow (SORCoT): a deployable network to rapidly establish and administer decentralized trials | Hall A | View Abstract |
WED | 178 | Alexander Verbitsky | Netrias | 167 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | AI-Driven Harmonization | Hall A | View Abstract |
TUES | 179 | Phillip Tomezsko | MIT Lincoln Laboratory | 242 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | AI-enabled property prediction for characterization of novel proteins | Hall A | Abstract unavailable. |
WED | 180 | Robert Gordon | Riskaware Ltd | 486 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | An edge/cloud wearable technologies data infrastructure for detecting biological threats and physiological stress | Hall A | View Abstract |
TUES | 181 | Miles Rogers | RTX BBN Technologies | 499 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | An Integrated Nanophotonic Biosensor for Biological and Chemical Threat Detection | Hall A | View Abstract |
TUES | 183 | Justin Taylor | Noblis | 98 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Applying Machine Learning and Statistical Models to Low-cost Aerosol Densors for Anomaly Detection | Hall A | View Abstract |
WED | 184 | Katherine Rhea | U.S. Army DEVCOM Chemical Biological Center | 476 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Assessing the relationship between functionality and proteome of cell-free protein systems from Yersinia pestis | Hall A | View Abstract |
TUES | 185 | Robert Murdoch | Battelle | 306 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | BAT-NET: Bioinformatics Analysis Tool for Network Evaluation of Threats | Hall A | View Abstract |
TUES | 186 | Stuart Lambert | Battelle | 456 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Quantum Multiplexed Molecular Nanoscale Sensors | Hall A | View Abstract |
TUES | 187 | Taylor Moehling | Sandia National Laboratories | 342 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Biophysics- and Biochemistry-Informed Machine Learning to Predict the Effect of Nucleotide Mutations on Molecular Detection Assays | Hall A | View Abstract |
WED | 188 | Chuck Smallwood | Sandia National Laboratories | 131 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Hall A | View Abstract |
TUES | 189 | Lennart Justen | Media Lab, Massachusetts Institute of Technology; Draper Laboratory | 201 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Biosurveillance of emerging viral threats through indoor air sampling | Hall A | View Abstract |
WED | 190 | Brandon Fields | Fieldstone Bio, Inc. | 383 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Biotechnology-enabled standoff detection and mapping of operationally relevant analytes | Hall A | View Abstract |
TUES | 191 | Mark Munson | Naval Medical Research Command - Biological Defense Research Directorate | 243 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Bridging study on transition of DBPAO assays to the Biomeme platform and additional assay development | Hall A | View Abstract |
WED | 192 | Rachel Sparklin | The Johns Hopkins University, Applied Physics Laboratory, Laurel, MD | 336 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Cas9-assisted enrichment of metagenomic sequencing samples | Hall A | View Abstract |
TUES | 193 | David Garcia | U.S. Army DEVCOM Chemical Biological Center | 621 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Cell-free Detection of Small-Molecules Using Nanobody Conjugates | Hall A | View Abstract |
WED | 194 | Dave Kimmel | Department of Homeland Security, Science and Technology | 338 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Characterizing the Bioaerosol Composition Using Metagenomic Sequencing for Environmental Biodetection | Hall A | View Abstract |
TUES | 195 | Ashish Chaudhary | Detect-ION | 273 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Chip-Scale Mass Spectrometry for Point-of-Care Breath Diagnostics | Hall A | View Abstract |
WED | 196 | Keersten Ricks | USAMRIID | 97 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Companion Animal Mortality from Oral Exposure to Palytoxin with First Confirmation of Exposure in Clinical Samples | Hall A | View Abstract |
TUES | 197 | Kelsey Hauser | Noblis | 696 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Computer Vision-Enabled Point-of-Care Biothreat Detection | Hall A | View Abstract |
WED | 200 | Robert Murdoch | BATTELLE MEMORIAL INSTITUTE | 638 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Detection of genomic aberrations in viral genomes by measurement of phylogenetic distant attraction | Hall A | View Abstract |
TUES | 201 | Julie Lucas | MRIGlobal | 462 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development and validation of ICECAP (Immobilized CRISPR Enriches Captured Target Pathogens) for on-demand pathogen detection | Hall A | View Abstract |
WED | 202 | Brian Lee | MIT Lincoln Laboratory | 149 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development of an LC-MS/MS-based integrated analysis pipeline for the detection of trace protein and small molecule toxins in complex matrices | Hall A | Abstract unavailable. |
TUES | 203 | Ian Davis | US Army Medical Research Institute of Infectious Diseases | 473 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development of immunoassays for CCHFV proteins | Hall A | View Abstract |
WED | 204 | Colin Price | MRIGlobal | 603 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development of the CasCADE CRISPR Detection guide RNA Design Pipeline | Hall A | View Abstract |
TUES | 205 | Jian Gu | The University of Arizona College of Medicine-Phoenix | 259 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development of the VeriFAST system for multi-echelon diagnostics of multiplex agents | Hall A | View Abstract |
WED | 206 | Brandon Pybus | USAMRIID | 236 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | DRAGON MEDIC, a paradigm for the rapid fielding of iterative prototype technology | Hall A | View Abstract |
TUES | 207 | David Rozak | USAMRIID | 407 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Evaluating engineered protease chain reactions as an adaptable, cross-platform technology for detecting new and emerging biological threat agents in laboratory and field environments | Hall A | View Abstract |
WED | 208 | Melissa Adams | USAMRIID | 86 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Far-forward real-time PCR assay manufacturing for rapid pathogen detection in austere or contested locations | Hall A | View Abstract |
TUES | 209 | Uma Balakrishnan | Sandia National Labs | 447 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | GenAI aided Synthetic Twin of a Population for Developing Accurate Low SWaP-C Multilayered Anomaly Detection | Hall A | View Abstract |
WED | 210 | Alberto Rios | USSOCOM | 173 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Genomic Non-specific Operational Matchmaking Enabled Systems (G-NOMES): Innovative acquisition for low-SWAP, modular, automated biological sample preparation for field forward agnostic sequencing for emerging biological threats | Hall A | View Abstract |
TUES | 211 | Maria Nevarez Martinez | Los Alamos National Laboratory | 265 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Giant quantum dots (gQDs) as fluorescent probes for improved antibody-antigen interaction studies through 3D quantum-enhanced single particle tracking | Hall A | View Abstract |
WED | 212 | Damian Honeyman | Kirby Institute | 143 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Global Event-based Surveillance of Chemical Incidents from Open-source Intelligence | Hall A | View Abstract |
TUES | 213 | Matthew Lux | U.S. Army DEVCOM Chemical Biological Center | 508 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Detecting emerging biological threats with Dial-a-Threat | Hall A | View Abstract |
WED | 214 | Karlyn Harrod | Oak Ridge National Laboratory, National Security Sciences Division | 566 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Integrating Biosurveillance and Climate Data for Vectorborne Disease Risk Mapping and Prediction | Hall A | View Abstract |
TUES | 215 | Srivatsan Raman | University of Wisconsin-Madison | 199 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Leveraging allosteric transcription factors to detect small molecule threats | Hall A | View Abstract |
WED | 216 | Kurt Gust | US Army Engineer Research and Development Center | 393 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Leveraging Cryptobiosis Mechanisms to Develop Ruggedized Cells for Biological Sensing in Austere Environments | Hall A | View Abstract |
TUES | 217 | Joshua Whiting | Sandia National Laboratories | 719 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Leveraging FAID for biological sample analysis | Hall A | View Abstract |
WED | 218 | Charles DeSanti | Battelle | 365 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Location-specific Volatile Organic Compounds detected in Bacillus anthracis Delta Sterne Spore preparations. | Hall A | View Abstract |
TUES | 219 | Casey Bernhards | U.S. Army DEVCOM Chemical Biological Center | 584 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Low burden sensors for in-field detection of water contaminants based on synthetic biology and cell-free expression systems | Hall A | View Abstract |
WED | 220 | Rahul Rao | Air Force Research Laboratory | 613 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Machine learning-enabled development of SERS sensors for the detection of trace analytes | Hall A | View Abstract |
TUES | 221 | Brian Lee | MIT Lincoln Laboratory | 47 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Merging Experimental and AI Approaches for Threat Characterization | Hall A | Abstract unavailable. |
WED | 222 | Bharat Poudel | Oregon State University | 722 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Metadynamics Free Energy Analysis of High Temperature Degradation of Fentanyl | Hall A | View Abstract |
TUES | 223 | Rebecca Lilly | The Johns Hopkins University Applied Physics Laboratory | 250 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Miniaturized Airborne Threat Assessment & Detection sensOR (MATADOR) | Hall A | View Abstract |
WED | 224 | Kevin Yehl | Miami University | 561 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Multiplexing DNA sensors and using pattern recognition to detect a range of chemical and biological threats using a single test platform | Hall A | View Abstract |
TUES | 225 | Kamil Khanipov | University of Texas Medical Branch | 307 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Nationwide Bioaerosol Metagenomic Repository for Environmental Biodetection | Hall A | View Abstract |
WED | 226 | Cory Bernhards | U.S. Army DEVCOM Chemical Biological Center | 670 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | NATO Technical Activity: Sequencing for Environmental Aerosol Background Monitoring | Hall A | View Abstract |
WED | 227 | Cory Bernhards | U.S. Army DEVCOM Chemical Biological Center | 316 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Development of untargeted nanopore-based systems for agnostic biological threat identification in the field | Hall A | View Abstract |
WED | 228 | Andrea Luquette | Naval Medical Research Command | 152 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Novel TaqMan Assay for the Detection of Mayaro Virus Circulation in South America | Hall A | View Abstract |
WED | 230 | Rachel Podgorski | USAMRIID | 591 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Pathogen Identification using Isothermal Amplification and Next-Generation Sequencing Technologies | Hall A | View Abstract |
TUES | 231 | Peggy Sammon | GeneCapture, Inc. | 261 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Pathogen X detection using one-hour screen in austere environments | Hall A | View Abstract |
WED | 232 | Jennifer Morales | DEVCOM Army Research Lab | 388 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Photonic Integrated Circuits and Protein Catalyzed Capture Agents as a Multiplexed, Heat and Shelf Stable Biosensor for Biological Targets | Hall A | View Abstract |
WED | 233 | Jennifer Morales | DEVCOM Army Research Lab | 389 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Ultra-low SWaP-C, Photonic Integrated Circuit sensors for the multiplexed detection of organo-phosphate simulants | Hall A | View Abstract |
WED | 234 | Christian Schafmeister | ThirdLaw Molecular LLC | 28 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Progress in developing SMBA(TM) - Spiroligomer Macromolecular Binding Agents to replace monoclonal antibodies in diagnostic tests | Hall A | View Abstract |
TUES | 235 | T.C. Folkedal | Noblis | 643 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | PSIDO: Predictive Surveillance of Infectious Disease Outbreaks | Hall A | View Abstract |
TUES | 237 | Darci Smith | Naval Medical Research Command | 448 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Rapid Detection of Blood Based Biomarkers for Emerging Biological Threats that Cause Brain Injury | Hall A | View Abstract |
WED | 238 | David Zipse | Chemring Sensors and Electronic Systems | 368 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Rapid, affordable, and scalable response to emerging biological threats | Hall A | View Abstract |
TUES | 239 | Joseph Lacirignola | MIT Lincoln Laboratory | 2 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | BEWARE: Biological Early Warning of Aerosol Risk and Exposure | Hall A | View Abstract |
WED | 240 | Christopher Harrilal | Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory | 713 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Reference-free chemical threat characterization | Hall A | View Abstract |
TUES | 241 | Sean Kinahan | DHS Science and Technology Directorate | 491 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Science Watch: A Systematic Approach to the Identification and Evaluation of Rapidly Evolving 21st Century Chemical and Biological Threats | Hall A | View Abstract |
TUES | 242 | Lloyd Hough | DHS Science and Technology Directorate | 495 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | The Five Research and Development (5RD) Council's Global Biodefense Network (GBDN) Approach to Synchronizing and Sharing Research in the Fate of Emergent Biological Agents in the Environment (FAtE) | Hall A | View Abstract |
TUES | 243 | Sean Kinahan | DHS Science and Technology Directorate | 693 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | The Department of Homeland Security S&T Master Question Lists Provide Decision Makers and Stakeholders Reference Information on Biological Agents | Hall A | View Abstract |
WED | 244 | Kemper Talley | RTX BBN Technologies | 279 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Secure Bloom-Filter Analysis of Sequenced Threats in Real-Time (SB-FASTR) for Wastewater | Hall A | View Abstract |
TUES | 245 | Sterling Sawaya | GeneInfoSec Inc. | 26 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Sharing Accurate and Secure Pathogen Genome Data | Hall A | View Abstract |
WED | 246 | Jennifer Stone | MRIGlobal | 466 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Simplification and Automation of a Biological Sequencing Workflow for Threat-Agnostic Detection in Field Settings | Hall A | View Abstract |
TUES | 247 | Jennifer Lee | Defense Threat Reduction Agency | 223 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Solution blow spinning of cell-free functionalized polymer fibers for the detection of emerging biological threats | Hall A | View Abstract |
TUES | 249 | Adina Doyle | U.S. Army DEVCOM Chemical Biological Center | 424 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Streamlining nanopore sequencing protocols for untargeted RNA virus identification in the field | Hall A | View Abstract |
WED | 250 | Oliver Nakano-Baker | University of Washington | 707 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | The bio-inspired nose-on-a-chip for mobile sensing and breath-based diagnostics | Hall A | View Abstract |
WED | 252 | Haydon Hill | University of Nevada, Reno School of Medicine | 743 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | The development of a portfolio of antibodies to facilitate the point-of-need detection of bacterial, viral, and toxin biothreats | Hall A | View Abstract |
TUES | 253 | Frederik Schulz | Lawrence Berkeley National Laboratory | 244 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Towards sequencing for agnostic discriminative detection of biological threats with outbreak potential | Hall A | View Abstract |
WED | 254 | Susan Kozawa | U.S. Army DEVCOM Chemical Biological Center | 592 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Utilization of Bioprinting to fabricate tunable tissues: a polymeric perspective | Hall A | View Abstract |
WED | 255 | Susan Kozawa | U.S. Army DEVCOM Chemical Biological Center | 593 | Protection - Science and Technology Advances for Chemical and Biological Protection | Understanding the effects of processing on fiber/Mof composites | Hall A | View Abstract |
WED | 256 | Christopher Puglisi | Netrias | 380 | Innovating Cross-domain Solutions to Detect Emerging Biological Threats | Viral threat detection from proteomics data with machine learning | Hall A | View Abstract |
TUES | 257 | Howard Walls | RTI International | 34 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | A Modular System Architecture for Securely acquiring, Transmitting, and Processing Data from Wireless Chem-bio Sensors | Hall A | View Abstract |
TUES | 259 | Shawna Gallegos | U.S. Army DEVCOM Chemical Biological Center & ORISE | 251 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | IronDog: Introducing the future four-legged warfighter | Hall A | View Abstract |
WED | 260 | Joshua Uzarski | U.S. Army DEVCOM Chemical Biological Center | 646 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | Novel Generative AI for sensors: augmenting downstream deployed sensors for improved agent detection and identification | Hall A | View Abstract |
TUES | 261 | Joseph Russell | MRIGlobal | 664 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | Seeing the trees for the forest -- Identifying trap-door genomics records ahead of your bioinformatics workflow | Hall A | View Abstract |
WED | 262 | Jordan Lefebvre | Aeris, LLC | 545 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | Tactical Awareness Kit Tactical Sensor Placement | Hall A | View Abstract |
TUES | 263 | David Godso | Domenix | 103 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | Unveiling Strategic Insights: Leveraging Domenix’s Unified Protocol Architecture for Enhanced Sensor Asset Management and AI/ML Integration. | Hall A | View Abstract |
WED | 264 | Charles Carrington | IndoorGEO, LLC | 311 | Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets | An Indoor Data Library to Support Situational Awareness and Targeting | Hall A | View Abstract |
TUES | 265 | Cecilia Phung | U.S. Army DEVCOM Chemical Biological Center | 348 | Localizing Chemical and Biological Threat Detection | Assessment of Surface and Ground hAzards by Real-time Detection (ASGARD): Deposition Methodology Development and Characterization | Hall A | View Abstract |
WED | 266 | Eric Peters | MRIGlobal | 400 | Localizing Chemical and Biological Threat Detection | Ballistic GC (BGC) for CWA Vapor Analysis | Hall A | View Abstract |
TUES | 267 | Kakali Bandyopadhyay | Airanaculus.com | 726 | Localizing Chemical and Biological Threat Detection | Biological and Chemical Threat Prediction and Reasoning System (BiCEPS) to aid detection of Biological and Chemical Threat | Hall A | View Abstract |
WED | 268 | Nicholas Fitzgerald | Defence Science and Technology Group - Department of Defence Australia | 419 | Localizing Chemical and Biological Threat Detection | CASES - A low-SWaP low-cost "wearable" for early warning of airborne pathogen exposure. | Hall A | View Abstract |
TUES | 269 | Steven Pullins | Leidos | 549 | Localizing Chemical and Biological Threat Detection | Aerosol Remote Sensing: the intelligent Chemical Aerosol Transmission Spectrometer (iCATS) | Hall A | View Abstract |
WED | 270 | Meredith Melendez | Leidos | 551 | Localizing Chemical and Biological Threat Detection | Aerosol Remote Sensing: The intelligent Chemical Aerosol Transmission Spectrometer (iCATS) Aerosol Test Chamber | Hall A | View Abstract |
TUES | 271 | Rajesh Agarwal | University of Colorado Anschutz Medical Campus | 247 | Localizing Chemical and Biological Threat Detection | Clinical biomarkers of acute toxicity induced by mustard vesicant exposure in the ocular tissue | Hall A | View Abstract |
TUES | 273 | Sara Paalhar | MRIGlobal | 402 | Localizing Chemical and Biological Threat Detection | Colorimetric Sensors for Rapid Reliable Threat Identification | Hall A | View Abstract |
TUES | 274 | Sara Paalhar | MRIGlobal | 403 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination Efficacy Testing for CWA Mitigation | Hall A | View Abstract |
TUES | 275 | Cody Corbin | Sandia National Laboratories | 17 | Localizing Chemical and Biological Threat Detection | Colorimetric/Electrical Sensing of Chemical Warfare Agent Surrogates with Polydiacetylenes | Hall A | View Abstract |
WED | 276 | Christopher Breshike | US Naval Research Laboratory | 58 | Localizing Chemical and Biological Threat Detection | Detection of Dimethyl Methylphosphonate (DMMP) with an Interband Cascade Laser Sensor | Hall A | View Abstract |
WED | 278 | Migun Shakya | Los Alamos National Laboratory | 579 | Localizing Chemical and Biological Threat Detection | Environmental Biomonitoring for Detecting Known and Unknown Pathogens | Hall A | View Abstract |
TUES | 279 | Jill Lundell | MIT Lincoln Laboratory | 513 | Localizing Chemical and Biological Threat Detection | Exploratory Analysis of Multi-sensor Wearables Data on Chemical Exposure | Hall A | View Abstract |
WED | 280 | Yongle Pan | DEVCOM Army Research Laboratory | 472 | Localizing Chemical and Biological Threat Detection | Fast Bioaerosol Warning Sensor Using Single Particle Differential Circular Polarization Scattering (CIDS) | Hall A | View Abstract |
TUES | 281 | Evan Durnal | MRIGlobal | 395 | Localizing Chemical and Biological Threat Detection | High-Purity Vapor Generation of Semi-Volatile Chemical Agents for Wearable Sensor Validation | Hall A | View Abstract |
TUES | 282 | Evan Durnal | MRIGlobal | 392 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination Efficacy Validations for Clandestine Site Remediation Motivating development of a standard practice | Hall A | View Abstract |
TUES | 283 | William Brubaker | SRI International | 729 | Localizing Chemical and Biological Threat Detection | Host-response biomarkers in interstitial fluid: individual baselines, marker kinetics, and implications for wearable devices and continuous monitoring. | Hall A | View Abstract |
WED | 284 | Vincent Farley | Telops | 649 | Localizing Chemical and Biological Threat Detection | Improved Chemical Gas Detection and Identification for Thermal Infrared Hyperspectral Remote Sensing | Hall A | View Abstract |
TUES | 285 | Daniel Reyes Duram | Institute for Human and Machine Cognition | 258 | Localizing Chemical and Biological Threat Detection | Improving CBRNE Situational Awareness using Wearable KENNEL Threat Detection Boxes | Hall A | View Abstract |
WED | 286 | David Schiering | Redwave Technology | 203 | Localizing Chemical and Biological Threat Detection | In-field Vapor Threat Identification Using FT-IR Spectroscopy in Mounted and Dismounted Modalities | Hall A | View Abstract |
TUES | 287 | Shawna Gallegos | U.S. Army DEVCOM Chemical Biological Center, Oak Ridge Institute for Science and Education, US Department of Energy (ORISE; Oak Ridge) | 232 | Localizing Chemical and Biological Threat Detection | Leveraging analytical chemistry and advanced flow visualization for the identification of trace levels of threat material | Hall A | View Abstract |
WED | 288 | Meghan Hegarty-Craver | RTI International | 33 | Localizing Chemical and Biological Threat Detection | Lightweight Wearables-based Algorithms for Detecting Exposure to Chemical, Biological, and Environmental Threats | Hall A | View Abstract |
WED | 289 | Meghan Hegarty-Craver | RTI International | 32 | Localizing Chemical and Biological Threat Detection | Using Wearables-based Health Data for AI-powered Diagnostics | Hall A | View Abstract |
TUES | 291 | Ambalavanan Jayaraman | TDA Research | 694 | Localizing Chemical and Biological Threat Detection | Person wearable sensors for chemical agent detection including TICs | Hall A | View Abstract |
WED | 292 | Donald Huston | National Strategic Research Institute (NSRI) | 678 | Localizing Chemical and Biological Threat Detection | Risk exposure and mitigation of potentially airborne infectious diseases on the USNS Mercy, a Navy hospital ship | Hall A | View Abstract |
TUES | 293 | Henry Maynard | Alakai Defense Systems | 567 | Localizing Chemical and Biological Threat Detection | Small Standoff Trace Detection Sensor for Handheld and UGV/UAV Applications | Hall A | View Abstract |
WED | 294 | Matthew Aernecke | 908 Devices | 475 | Localizing Chemical and Biological Threat Detection | The Risk Disk – a platform for forward deployed chemical collection and analysis | Hall A | View Abstract |
TUES | 295 | Miles Egan | Leidos | 555 | Localizing Chemical and Biological Threat Detection | Trace Aerosol Signature Detection and Classification Using Standoff Quantum Cascade Laser Absorption Spectroscopy: Preliminary Forward Modeling Results from the IARPA PICARD Program | Hall A | View Abstract |
WED | 296 | Brian Thomson | N5 Sensors Inc. | 518 | Localizing Chemical and Biological Threat Detection | Wearable chemical sensors for improved situational awareness | Hall A | View Abstract |
TUES | 297 | Philip Miller | Sandia National Laboratories | 735 | Localizing Chemical and Biological Threat Detection | Wearable Chemical Threat and Volatile Organic Compound Detector | Hall A | View Abstract |
WED | 298 | Jefferey Borenstein | Draper Lab | 465 | Medical Prophylaxis to Mitigate Chemical Threats | A high-throughput human primary cell-based blood-brain barrier model for evaluation of treatments and prophylaxis for nerve agents | Hall A | View Abstract |
TUES | 299 | Joe Harford | SynerGene Therapeutics, inc. | 37 | Medical Prophylaxis to Mitigate Chemical Threats | An oxime nanoformulation designed to cross the blood-brain barrier results in more brain acetylcholinesterase reactivation, less brain damage, and better survival rates in paraoxon-exposed mice | Hall A | View Abstract |
TUES | 301 | Lukas Gorecki | University Hospital Hradec Kralove, Biomedical Research Center | 130 | Medical Prophylaxis to Mitigate Chemical Threats | Bifunctional Compounds Serving As Versatile Causal Antidotes Against Nerve Agents | Hall A | View Abstract |
WED | 302 | Joseph Morgan | Kotzker Phfarma, LLC | 147 | Medical Prophylaxis to Mitigate Chemical Threats | Cannabinoids for Prophylaxis, Enhanced Neuroprotection and Therapy Against Organophosphate (OP) Chemical War Nerve Agents | Hall A | View Abstract |
TUES | 303 | Terry Thiem | National Strategic Research Institute | 590 | Medical Prophylaxis to Mitigate Chemical Threats | Continuous Subcutaneous Infusion of SEVALENT Formulations Enabling Prophylactic Use of CBRN Medical Countermeasures | Hall A | View Abstract |
WED | 305 | Marco Pravetoni | University of Washington | 602 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Rational design of antibody-based countermeasures against fentanyl, carfentanil, and ultrapotent synthetic opioids | Hall A | View Abstract |
WED | 306 | James Talton | Alchem Laboratories Corp. | 27 | Medical Prophylaxis to Mitigate Chemical Threats | Discovery and Development of Small Molecule AChE Reactivators | Hall A | View Abstract |
TUES | 307 | Sofiya Micheva-Viteva | Los Alamos National Laboratory | 181 | Medical Prophylaxis to Mitigate Chemical Threats | Discovery of Therapeutic Countermeasures Against Injuries Induced by Nerve Agents | Hall A | View Abstract |
WED | 308 | Mital Patel | Walter Reed Army Institute of Research | 211 | Medical Prophylaxis to Mitigate Chemical Threats | Dose-dependent Effects of Fentanyl in Mouse Cortex: An Integrative mRNA-miRNA Profiling Approach | Hall A | View Abstract |
TUES | 309 | John McManus | Partner Therapeutics, Inc. | 510 | Medical Prophylaxis to Mitigate Chemical Threats | Expanding the use of an FDA-approved host-directed therapy for known and unknown threats: Treating pancytopenia and immune dysregulation due to acute radiation or sulfur mustard (HD) exposure with Leukine® [sargramostim/recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF)] | Hall A | View Abstract |
WED | 310 | Bob Moyer | Battelle | 300 | Medical Prophylaxis to Mitigate Chemical Threats | In Vitro Assessment of the Ferret Model for Nerve Agent Medical Countermeasure Evaluation | Hall A | View Abstract |
WED | 312 | Genesis Lopez-Cazares | Sandia National Laboratories | 573 | Medical Prophylaxis to Mitigate Chemical Threats | Optimization of Lipid-Coated Mesoporous Silica Nanoparticles for BBB targeted delivery of 2-PAM to the CNS | Hall A | View Abstract |
TUES | 313 | Katie Davis-Anderson | CFD Research | 132 | Medical Prophylaxis to Mitigate Chemical Threats | Organophosphate nerve agent-induced transcriptome changes in human cells to identify drug targets | Hall A | View Abstract |
WED | 314 | Manish Moghe | Georgetown University Medical Center | 38 | Medical Prophylaxis to Mitigate Chemical Threats | Preventing neuronal losses after organophosphate exposures by curbing neuroinflammation via a novel nanoformulation of pralidoxime designed to cross the blood-brain barrier | Hall A | View Abstract |
TUES | 315 | Kevin Miller | Ohio State University | 317 | Medical Prophylaxis to Mitigate Chemical Threats | Protection Against Organophosphorus Threats: Quinone Methide Precursors for the Broad-Scope Treatment of OP-Inhibited AChE and BChE, and OP-Aged AChE | Hall A | View Abstract |
WED | 316 | Christopher Hadad | Ohio State University | 312 | Medical Prophylaxis to Mitigate Chemical Threats | Quinone Methide Precursors for Remediating Organophosphorus Intoxication: Novel Reactivators of OP-inhibited and Resurrectors of OP-aged Cholinesterases | Hall A | View Abstract |
WED | 318 | Jonathan Boyd | Virginia Commonwealth University | 101 | Medical Prophylaxis to Mitigate Chemical Threats | Spatiotemporal Inflammation Following Chemical Agent Exposure: Fentanyl Survival in Mice | Hall A | View Abstract |
TUES | 319 | Jennie Wang | SRI | 160 | Medical Prophylaxis to Mitigate Chemical Threats | Stability-indicating HPLC Method Development and Impurity Characterization for a Broad-spectrum Reactivator Against a Highly Toxic Organophosphorus Compound, HLö 7 dimethanesulfonate (HLö 7 DMS) | Hall A | View Abstract |
WED | 320 | Emilia Solomon | Los Alamos National Laboratory | 129 | Medical Prophylaxis to Mitigate Chemical Threats | Tissue Protective and Regenerative Therapies Counteracting Nerve Agent Damage | Hall A | View Abstract |
TUES | 321 | Brian Jun | Los Alamos National Laboratory | 601 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | 3D-Printed Perfusion Bioreactor for Brain Vascular Permeability Assessment | Hall A | View Abstract |
WED | 322 | Taalin Hoj | United States Army Research Institute of Infectious Disease | 337 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Comparing Immune Responses to B. pseudomallei Infection in a Lymphoid Follicle MPS and a C57BL/6 Mouse Model | Hall A | View Abstract |
TUES | 323 | S. Emma Sarles | U.S. Army DEVCOM Chemical Biological Center | 176 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Exploration of in vitro methods for investigating mechanism of action of Sulfur Mustard (HD) | Hall A | View Abstract |
WED | 324 | Priscilla Lee | U.S. Army DEVCOM Chemical Biological Center | 174 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Bioprinting a skin model to assess the toxicity of sulfur mustard | Hall A | View Abstract |
TUES | 325 | Joshua Dye | Darwin Biosciences | 581 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Improving point-of-need diagnostic readouts across amplification chemistries | Hall A | View Abstract |
WED | 326 | Harshini Mukundan | Lawrence Berkeley National Laboratory | 257 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Innate Immunity as a Model System for Development of Agnostic Diagnostics for Known and Emerging Threats | Hall A | View Abstract |
TUES | 327 | Krysten Jones | Air Force Research Laboratory | 469 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Integrated Human Neurovascular Unit-on-a-Chip for Machine Learning-based Prediction of Neurotoxin Exposure | Hall A | View Abstract |
WED | 328 | Gillian McMahon | University of California, San Diego | 585 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Leveraging human organoid models and advanced microscopy to probe 4D mitochondrial dynamics with applications in drug development and toxicology | Hall A | View Abstract |
TUES | 329 | David Trudil | New Horizons Diagnostics Corporation | 679 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Linear Peptide Micro Array Platform for Development of Mucosal Immune Enhancers and Saliva-Based Diagnostics | Hall A | View Abstract |
WED | 330 | Daniel Angelini | U.S. Army DEVCOM Chemical Biological Center | 208 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Multiomic Comparison of Sulfur Mustard-exposed Human and Rat EpiAirway Tissues. | Hall A | View Abstract |
TUES | 331 | Rebecca Blackwood | Darwin Biosciences, Boulder | 609 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Optimization of a point-of-need infectious disease diagnostic through human factors and usability testing | Hall A | View Abstract |
WED | 332 | Elizabeth Dhummakupt | U.S. Army DEVCOM Chemical Biological Center | 229 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Soldier-on-a-chip: Multi-omic investigation of Staphylococcal Entertoxin B exposures in Microphysiology systems | Hall A | View Abstract |
TUES | 333 | Maria Arevalo | U.S. Army DEVCOM Chemical Biological Center | 168 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Towards the agnostic future of diagnostics: untargeted nanopore sequencing of biological fluids | Hall A | View Abstract |
WED | 334 | April Kloxin | University of Delaware | 543 | Microphysiological Systems as Tools for Non-Invasive Diagnostics | Well-defined bioinspired multidimensional culture systems for studying cellular responses to injury and pathogens | Hall A | View Abstract |
TUES | 335 | Sangram Redkar | Arizona State University | 108 | Minds in Sync: Exploring the Nexus of Humans on a Chip and Wearable Technologies on Cognitive Measures of Human Performance | Ear Wearable Device (EWD) for Measuring Core Body Temperature, EKG, SpO2 and Other Physiological Signatures. | Hall A | View Abstract |
TUES | 336 | Sangram Redkar | Arizona State University | 107 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Towards Chemical Exposure Detection: A Deep Learning Approach for Retinal Image Feature Mapping | Hall A | View Abstract |
TUES | 337 | Laura Weinstock | Sandia National Laboratories | 409 | Minds in Sync: Exploring the Nexus of Humans on a Chip and Wearable Technologies on Cognitive Measures of Human Performance - Session Chairs: Sweta Batni and Chia-Wei Tsai | An Applied Risk Assessment Methodology for Identification, Prioritization, and Mitigation of Adverse Events from Emerging Neurotechnology | Hall A | View Abstract |
TUES | 338 | Laura Weinstock | Sandia National Laboratories | 373 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Mixed CNN-Attention machine learning model for predicting gene regulatory relationships across fungal species towards developing computational methods for defending against emerging pathogenic fungi. | Hall A | View Abstract |
TUES | 339 | Rohit Nagarimadugu | U.S. Army Medical Research Institute of Chemical Defense | 537 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Special Matrix Applied Reactive Treatment (SMART) Bandage: PTE-CBM, A Binding Solution to a Lethal Problem | Hall A | View Abstract |
WED | 340 | Sarah Katoski | U.S. Army DEVCOM Chemical Biological Center | 177 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | A Design for Decon | Hall A | View Abstract |
WED | 342 | Steve Hughes | SteriO3 LLC | 417 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Autonomous Surface and Airborne Chemical and Biological Decontamination Via Peroxide Enhanced Germicidal Irradiation (PEGI) | Hall A | View Abstract |
TUES | 343 | Katrina McConkey | Environmental Protection Agency | 191 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Biological Incident Response: Building Knowledge Through Operational Testing and Exercises | Hall A | View Abstract |
WED | 344 | Joseph Myers | U.S. Army DEVCOM Chemical Biological Center | 162 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Chemical Hot Air Decontamination of Complex Features and Realistic Items | Hall A | View Abstract |
WED | 345 | Josephe Myers | U.S. Army DEVCOM Chemical Biological Center | 164 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination of Chemical Contaminants from Sub-zero to Hot temperatures | Hall A | View Abstract |
WED | 346 | Sooyeon Cho | Sungkyunkwan University | 114 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Cold Atmospheric Plasma Based H2O2 Decontaminant Production and Its On-Site and Real-Time Diagnostic System | Hall A | View Abstract |
TUES | 347 | Namjun Kim | Agency For Defense Development | 283 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Degradation mechanism of Organophosphate-Based Nerve Agents in the Plasma-Treated Water Environment: Theoretical Study of Decomposition Reaction under Acidic Condition | Hall A | View Abstract |
WED | 348 | Sangmoon Byun | Agency for Defense Development | 282 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination experiments on various contaminated coupons by chemical warfare agents | Hall A | View Abstract |
TUES | 349 | Joel Cooper | Triton Systems, Inc. | 569 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination of Broad Spectrum Biological Threats using an Atmospheric Plasma System | Hall A | View Abstract |
WED | 350 | Rachel Harding | Guild Associates, Inc. | 123 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Decontamination of Unbroken Skin | Hall A | View Abstract |
TUES | 351 | Lim Ji Won | Agency for Defense Development | 284 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Development and Implications of a Prototype Explosive Detonation System for the Demilitarization of Chemical Weapons in ROK | Hall A | View Abstract |
WED | 352 | eunmee goh | Agency for defense development | 145 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Development of Unmanned Operation Indoor Decontamination System | Hall A | View Abstract |
TUES | 353 | Janlyn Eikenberg | U.S. Army DEVCOM Chemical Biological Center | 180 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Development of a Chemical Decontaminant for Critical Areas | Hall A | View Abstract |
WED | 354 | Tony Buhr | Naval Surface Warfare Center - Dahlgren | 647 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Disinfection of Building, Facility, and Platform Interiors | Hall A | View Abstract |
WED | 355 | Tony Buhr | Naval Surface Warfare Center - Dahlgren | 640 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | CORONAVIRUSES (CV) AND Φ6 CORRELATION TESTING TO CHARACTERIZE ENVELOPED VIRUS PREPARATION, VIRUS DEBRIS, STABILIZATION AND DECONTAMINATION | Hall A | View Abstract |
WED | 356 | Lawrence Dubois | Nanoionix, LLC | 480 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Durable, permanent self-decontaminating paints and coatings for defense applications | Hall A | View Abstract |
TUES | 357 | John Pittman | Emergent BioSolutions Inc. | 15 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Efficacy of RSDL® (Reactive Skin Decontamination Lotion Kit) against Novichok Nerve Agents | Hall A | View Abstract |
WED | 358 | Marilyn Lee | U.S. Army DEVCOM Chemical Biological Center | 340 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Encapsulation of cell-free bio-reactions: delivering DNA-programmable functions to materials | Hall A | View Abstract |
WED | 360 | Brent Mantooth | U.S. Army DEVCOM Chemical Biological Center | 291 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Hazard mitigation - from science to systems | Hall A | View Abstract |
TUES | 361 | Jani Hakala | VTT Technical Reseach Centre of Finland | 144 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Heatless Vaporization of Liquid Decontaminants | Hall A | View Abstract |
WED | 362 | Brian Zutter | Sandia National Laboratories | 359 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | High-Current-Density Microbial Fuel Cells for Wastewater Bioremediation | Hall A | View Abstract |
TUES | 363 | Jeff Canning | Gamma Pulse | 658 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | How KillViD, a pulse powered plasma solution achieves 100% biological air contaminate destruction: Bench testing and live environment testing results | Hall A | View Abstract |
WED | 364 | Andres Sanchez | Sandia National Laboratories | 483 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Mitigating aerosolized threats with the Spray Knockdown system in a wide area urban transportation environment | Hall A | View Abstract |
TUES | 367 | Chris Hollars | MRIGlobal | 397 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Next Generation Expeditionary Infrastructure: ATHENA | Hall A | View Abstract |
WED | 368 | Kyeong Min Cho | Agency for Defense Development | 457 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | On-site and on-demand Production of Decontaminant Using Plasma Feactor | Hall A | View Abstract |
WED | 369 | Kyeong Min Cho | Agency for Defense Development | 455 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Development of Aerosol Decontamination Module for Autonomous Indoor Decontamination System | Hall A | View Abstract |
WED | 370 | Chin Li Cheung | University of Nebraska-Lincoln | 184 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Plasma-assisted Destruction of Fenitrothion by a Falling-Film Plasma Reactor | Hall A | View Abstract |
TUES | 371 | Hermes Huang | Smiths Detection | 345 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Proximate Chemical Agent Detector (PCAD) Testing at Desert Tempest 2024 for Vehicle Decontamination Assessment | Hall A | View Abstract |
WED | 372 | W. Bruce Salter | ARCTOS Technology Solutions | 79 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Renewable Antimicrobial Paints for Interior Surfaces | Hall A | View Abstract |
TUES | 373 | Zachary Canter | US Army Medical Research Institute of Chemical Defense | 276 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | SkinKast: A multi-modal dermal disclosure spray for the rapid detection of chemical warfare agents on intact skin | Hall A | View Abstract |
WED | 374 | Shawn Stevenson | U.S. Army DEVCOM Chemical Biological Center | 200 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | The evaluation of contaminant emission and transfer from a “used” decontaminant | Hall A | View Abstract |
TUES | 375 | Hunter Vibbert | JHU/APL | 663 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Threat Agnostic Fenton Decon | Hall A | View Abstract |
WED | 378 | Robert diTargiani | USAMRICD | 597 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Wound Decontamination Evaluation Pipeline (WDEP): Decontamination of wounds contaminated with chemical warfare agents | Hall A | View Abstract |
TUES | 379 | David Morton | DHS S&T CSAC | 586 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | : Chemical Forensics Decision Support via the Chemical Agents Reactions Database (CARD) | Hall A | View Abstract |
WED | 380 | James Lee | NSWCIHD | 234 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Testing Methods for Interpreting or Explaining Artificial Intelligence | Hall A | View Abstract |
WED | 381 | Tim Burgin | NSWCIHD | 235 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Group Contribution Model for the Accurate Calculation of Molecular Ionization Energies | Hall A | View Abstract |
WED | 382 | Samantha Erwin | Pacific Northwest National Laboratory | 429 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | An AI-Driven Security Platform for Threat Awareness and Decision Support | Hall A | View Abstract |
TUES | 383 | Stephen Houghton | SRC Inc. | 500 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Automated Property Prediction and Material File Generation for Hazard Prediction using PropCast | Hall A | View Abstract |
WED | 384 | Stephen Davis | Battelle Memorial Institute | 43 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Chemical Fires Module (CFM) Updates – Battery Fire | Hall A | View Abstract |
TUES | 385 | Abigail Enders | Battelle Memorial Institute | 541 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Climate-based forecasting of dengue virus cases and vector habitat suitability in the United States | Hall A | View Abstract |
WED | 386 | Catherine Fromen | University of Delaware | 423 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Development of an autonomous inhalation robot for chem/bio (AIR-CB) for real-world estimation of aerosolized threats | Hall A | View Abstract |
TUES | 387 | Sian Jenkins | Riskaware Ltd | 490 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Enabling decision support with Next Generation disease forecasting and chemical hazard prediction. | Hall A | View Abstract |
WED | 388 | Jennifer Corbin | Deloitte | 641 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Epidemiological Model Selection | Hall A | View Abstract |
TUES | 389 | Michael Sohn | Lawrence Berkeley National Laboratory | 697 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Integrated Urban: Vision and Results for the Urban Hazard Assessment Capability | Hall A | View Abstract |
TUES | 390 | Michael Sohn | Lawrence Berkeley National Laboratory | 698 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Propagating Uncertainty through Building Models | Hall A | View Abstract |
TUES | 391 | Mario Citra | SRC Inc. | 489 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Strategies for Whole Body Combined Exposure - Focus on Nerve Agents for FXCODA | Hall A | View Abstract |
WED | 392 | Paul Bieringer | Aeris, LLC | 531 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | The Joint Outdoor-indoor Large Eddy Simulation (JOULES) for numerical weather prediction forecasting and analysis in urban environments | Hall A | View Abstract |
TUES | 393 | Taylor Anderson | Naval Surface Warfare Center Indian Head Division | 371 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | The US Navy Shipboard Performance Model | Hall A | View Abstract |
WED | 394 | Kyle Niezgoda | Aeris, LLC | 535 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Transport and Dispersion Forecasting for Semi-Enclosed Venues: A Case Study at Stade de France using JOULES-NWP | Hall A | View Abstract |
TUES | 395 | Paul Fenimore | Los Alamos National Laboratory | 375 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Uncertainty Quantification for Epidemiological Decision Support and Quantification of Mitigation Effectiveness | Hall A | View Abstract |
TUES | 397 | Zheng Wang | US Naval Research Laboratory | 648 | Protection - Science and Technology Advances for Chemical and Biological Protection | 2D Melanin Coatings for Chemical Warfare Agent Protection | Hall A | View Abstract |
WED | 398 | Jeong-Yu Son | ADD | 277 | Protection - Science and Technology Advances for Chemical and Biological Protection | A decontamination study on a range of coupons contaminated by chemical warfare agents through an aerosol system | Hall A | View Abstract |
TUES | 399 | Sang Myeon Lee | Agency for Defense Development | 142 | Protection - Science and Technology Advances for Chemical and Biological Protection | Alginate-based Composite Materials for Uses in Protection and Decontamination against Chemical Warfare Agents | Hall A | View Abstract |
WED | 400 | Gary Piteo | U.S. Army DEVCOM Chemical Biological Center | 615 | Protection - Science and Technology Advances for Chemical and Biological Protection | Aerosol Fluorescence in the Active Standoff Chamber | Hall A | View Abstract |
TUES | 401 | Joe Myers | U.S. Army Chemical Biological Center | 339 | Protection - Science and Technology Advances for Chemical and Biological Protection | Decontamination of Aircraft Interiors | Hall A | View Abstract |
WED | 402 | William Creasy | U.S. Army Chemical Biological Center | 253 | Protection - Science and Technology Advances for Chemical and Biological Protection | Dependence of VX NMR Chemical Shifts on Mof (UIO-66-NH2) Solid | Hall A | View Abstract |
TUES | 403 | James Montavon | Blueprint Biosecurity | 587 | Protection - Science and Technology Advances for Chemical and Biological Protection | Far-UVC for biodefense: Opportunities and research priorities | Hall A | View Abstract |
WED | 404 | Andrew Kuznicki | DTRA | 218 | Protection - Science and Technology Advances for Chemical and Biological Protection | Design of Zeolitic Imidazolate Frameworks Towards a More Efficient Sulfur Dioxide Adsorbent | Hall A | View Abstract |
TUES | 405 | Gina Bang | Agency for Defense Development | 281 | Protection - Science and Technology Advances for Chemical and Biological Protection | Development and characterization of a Cu-Mg-Ce metal oxide composite for efficient degradation of DMMP | Hall A | View Abstract |
WED | 406 | Trenton Tovar | U.S. Army DEVCOM Chemical Biological Center | 165 | Protection - Science and Technology Advances for Chemical and Biological Protection | Development of novel broad-spectrum sorbent to extend the lifetime of collective protection filters | Hall A | View Abstract |
WED | 408 | Martijn de Koning | TNO Defence, Safety & Security | 477 | Protection - Science and Technology Advances for Chemical and Biological Protection | Dual-Functional Mofs: Efficient Adsorption and Degradation of a Nerve Agent Simulant and a Pesticide for Protective Applications | Hall A | View Abstract |
TUES | 409 | Seungjung Yu | Agency for Defense Development | 156 | Protection - Science and Technology Advances for Chemical and Biological Protection | Dynamic Swatch Test Method for Assessing Liquid Aerosol Penetration in Chemical Warfare Protective Clothing | Hall A | View Abstract |
WED | 410 | Yongkyu An | Engineer Research and Development Center (ERDC) of the US Army Corps of Engineers | 512 | Protection - Science and Technology Advances for Chemical and Biological Protection | Effect of Envelope Tightening on Collective Biological Protection of Buildings | Hall A | View Abstract |
TUES | 411 | Hui Wang | U.S. Army DEVCOM Chemical Biological Center | 166 | Protection - Science and Technology Advances for Chemical and Biological Protection | Elastomeric, omniphobic composites for protection applications | Hall A | View Abstract |
WED | 412 | Philip Cox | Mainstream Engineering | 470 | Protection - Science and Technology Advances for Chemical and Biological Protection | Encapsulated polymeric structured metal organic framework beads for adsorption and reaction of toxic agents | Hall A | View Abstract |
TUES | 413 | Behzad Rad | Lawrence Berkeley National Labs | 685 | Protection - Science and Technology Advances for Chemical and Biological Protection | Engineering Microbial Armor for Threat Detection | Hall A | View Abstract |
WED | 414 | Kelly Basi | U.S. Army DEVCOM Chemical Biological Center | 170 | Protection - Science and Technology Advances for Chemical and Biological Protection | Establishment of a Biomanufacturing Pipeline to Support Alternative Manufacturing of Chem-Bio Defense Materials and to Secure Supply Chain Resiliency | Hall A | View Abstract |
WED | 416 | Nevine Amer | University of Hertfordshire | 441 | Protection - Science and Technology Advances for Chemical and Biological Protection | Exploring the Skin Decontamination Potential of a Novel Zirconium Hydroxide Prototype against Chemical Warfare Agents with Comparative Analysis to RSDL | Hall A | View Abstract |
TUES | 417 | Mark Ginsberg | ERDC-CERL | 528 | Protection - Science and Technology Advances for Chemical and Biological Protection | Extended bioprotection of facilites | Hall A | View Abstract |
WED | 418 | Chase Thompson | U.S. Army DEVCOM Chemical Biological Center | 178 | Protection - Science and Technology Advances for Chemical and Biological Protection | Fabrication of Novel Functional Composite Forms for Filtration | Hall A | View Abstract |
TUES | 419 | Sergio Garibay | U.S. Army DEVCOM Chemical Biological Center | 216 | Protection - Science and Technology Advances for Chemical and Biological Protection | Formulation of chitosan-Mof-808 core-shell fibers for organophosphate hydrolysis under non-buffered conditions | Hall A | View Abstract |
TUES | 421 | Jennifer Poole | Teledyne FLIR Defense | 634 | Protection - Science and Technology Advances for Chemical and Biological Protection | Integrated Soldier Protection System (ISPS): A Nanomanufactured Textile Composite Designed for in situ Chemical and Biological Agent Neutralization | Hall A | View Abstract |
WED | 422 | Rashell McDonald | Air Force Civli Engineer Center | 321 | Protection - Science and Technology Advances for Chemical and Biological Protection | Investigating the efficacy of multiple catalysts for protection against vaporous CWAs | Hall A | View Abstract |
TUES | 423 | Katherine Ratliff | U.S. Environmental Protection Agency | 331 | Protection - Science and Technology Advances for Chemical and Biological Protection | Large-scale Bioaerosol Experiments to Support Enhanced Bioprotection of Facilities | Hall A | View Abstract |
WED | 424 | Bryan Koene | Luna Labs, LLC | 154 | Protection - Science and Technology Advances for Chemical and Biological Protection | Next Generation, PFAS-free Class I CBRN Gloves | Hall A | View Abstract |
TUES | 425 | Mohammad Khurram Javed | Virginia Tech | 120 | Protection - Science and Technology Advances for Chemical and Biological Protection | Macromorphological Control of Zr-based Metal-Organic Frameworks for Hydrolysis of a Nerve Agent Simulant | Hall A | View Abstract |
WED | 426 | Anna Shneidman | Harvard University | 747 | Protection - Science and Technology Advances for Chemical and Biological Protection | Materials for energy storage for around-the-clock photocatalysis | Hall A | View Abstract |
TUES | 427 | Benoit Maze | NCSU/NWI | 30 | Protection - Science and Technology Advances for Chemical and Biological Protection | Meltblown Coform for Chemical Protection Applications | Hall A | View Abstract |
WED | 428 | Adam Hinkle | DCS Corporation, DEVCOM Chemical Biological Command | 227 | Protection - Science and Technology Advances for Chemical and Biological Protection | Molecular Simulation of the Activation of Metal Organic Frameworks | Hall A | View Abstract |
TUES | 429 | James Whitten | Chemistry, University of Massachusetts Lowell | 293 | Protection - Science and Technology Advances for Chemical and Biological Protection | Multifunctional electrospun membranes on nylon-cotton fabrics for warfighter chemical protection | Hall A | View Abstract |
WED | 430 | Ching Hsien Ho | University of Massachusetts Amherst | 669 | Protection - Science and Technology Advances for Chemical and Biological Protection | Nanocellulose ionogels for CWA protection | Hall A | View Abstract |
TUES | 431 | Kevin Ulmes | U.S. Army DEVCOM Chemical Biological Center | 386 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | RaDaRR: Unlocking Historical Data for Rapid Threat Assessment | Hall A | View Abstract |
TUES | 432 | Kevin Ulmes | U.S. Army DEVCOM Chemical Biological Center | 384 | Protection - Science and Technology Advances for Chemical and Biological Protection | Nerve Agent ChE Operational Impact from Dermal Exposures | Hall A | View Abstract |
TUES | 433 | Caspar Hoyer | University of Hertfordshire | 452 | Protection - Science and Technology Advances for Chemical and Biological Protection | Next Generation Technologies for Real-Time Evaluation of Protective Suits against Toxic Chemicals | Hall A | View Abstract |
WED | 434 | Eric Prast | XCMR Inc. | 564 | Protection - Science and Technology Advances for Chemical and Biological Protection | Next-generation respiratory protective equipment for inactivation of airborne biological threats | Hall A | View Abstract |
TUES | 435 | Josh O'Daniel | Battelle | 358 | Protection - Science and Technology Advances for Chemical and Biological Protection | Omniphobic surfaces by engineering coatings with nanomaterials to control microscale topology | Hall A | View Abstract |
WED | 436 | Henry Gibbons | UU.S. Army DEVCOM Chemical Biological Center | 688 | Protection - Science and Technology Advances for Chemical and Biological Protection | Rapid Biotechnology Prototyping Consortium | Hall A | View Abstract |
WED | 438 | Brian France | TDA Research, Inc. | 727 | Protection - Science and Technology Advances for Chemical and Biological Protection | Reactive Materials for Personal Protective Equipment | Hall A | View Abstract |
WED | 439 | Brian France | TDA Research, Inc. | 157 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Protecting Military Working Dogs in a Contaminated Environment | Hall A | View Abstract |
WED | 440 | John Dresios | Leidos | 607 | Protection - Science and Technology Advances for Chemical and Biological Protection | Reconfigurable, Functionalized Fabric Platform for Broad Spectrum Chemical and Biological Protection | Hall A | View Abstract |
WED | 442 | Arshia Sulaiman | Virginia Tech | 78 | Protection - Science and Technology Advances for Chemical and Biological Protection | Manganese Single Atoms Modification of MOF-808 for Nerve Agent and Simulant Degradation | Hall A | View Abstract |
TUES | 443 | Francesco Fornasiero | Lawrence Livermore National Laboratory | 182 | Protection - Science and Technology Advances for Chemical and Biological Protection | Single-atom-catalyst Membranes for Chem/bio Protection | Hall A | View Abstract |
TUES | 446 | Lauren Sherry | Guild Associates Inc | 362 | Protection - Science and Technology Advances for Chemical and Biological Protection | Supplemental Filter for Enhanced TICs Removal | Hall A | View Abstract |
TUES | 447 | Daniel Freedman | U.S. Army DEVCOM Soldier Center | 90 | Protection - Science and Technology Advances for Chemical and Biological Protection | The influence of textile properties on chemical-biological protective garment design and thermal burden | Hall A | View Abstract |
WED | 448 | Wesley Gordon | US Army DEVCOM Chemical Biological Center | 219 | Protection - Science and Technology Advances for Chemical and Biological Protection | Theoretical study of chemical warfare agent and reaction byproduct molecular structure: Enabling FTIR analysis | Hall A | View Abstract |
TUES | 449 | Jimmy Nguyen | North Carolina State University | 370 | Protection - Science and Technology Advances for Chemical and Biological Protection | Toxic organophosphonate captured and degraded using macroscopic, monolithic metal-organic framework structures | Hall A | View Abstract |
WED | 450 | Daniel Corbin | US Naval Research Laboratory | 357 | Protection - Science and Technology Advances for Chemical and Biological Protection | Tunable Adsorbents for Hazardous Chemicals by Post-Synthetic Modification of Zirconium Metal-Organic Frameworks | Hall A | View Abstract |
TUES | 451 | Cody Kendig | U.S. Army DEVCOM Chemical Biological Center | 503 | Protection - Science and Technology Advances for Chemical and Biological Protection | Utilizing advanced manufacturing technologies to enhance legacy production techniques for next generation personal protective equipment | Hall A | View Abstract |
TUES | 453 | Phillip Wilcox | U.S. Army DEVCOM Chemical Biological Center | 171 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Assessment of Surface and Ground hAzards by Real-time Detection (ASGARD) – Proximate Chemical Agent Detector (PCAD) | Hall A | View Abstract |
WED | 454 | Angela Zeigler | U.S. Army DEVCOM Chemical Biological Center | 765 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Deployable Integrated Microsensor Evaluation System (DIMES) | Hall A | View Abstract |
TUES | 455 | Jennifer Mobberley | Pacific Northwest National Laboratory | 542 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Detection of Enzymatic Activity using Commercial-off-the-Shelf (COTS) Nanopore Sequencing-based Instrument | Hall A | View Abstract |
WED | 456 | Eric Languirand | U.S. Army DEVCOM Chemical Biological Center | 255 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Emergent explosive threats for use with threat anomaly detection (ThreAD) | Hall A | View Abstract |
WED | 457 | Eric Languirand | U.S. Army DEVCOM Chemical Biological Center | 254 | Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation | Novel radial jet reattachment for analyte extraction from porous surfaces | Hall A | View Abstract |
WED | 458 | Anthony Casale | US Army DEVCOM Chemical Biological Center | 240 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | First-principles analysis of transition metal nitrates in oxide host sensor materials | Hall A | View Abstract |
TUES | 459 | Joseph Palomba | U.S. Army DEVCOM Soldier Center | 290 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Hydrogel Technology for Emerging Colorimetrics (HyTEC): Metamaterials and Peptide Recognition Elements Combined for Eye-Readable Sensors | Hall A | View Abstract |
WED | 460 | Benjamin McDowell | Leidos | 709 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Improving SWaP in THz detection using a laser-cooled Rydberg atomic sensor on a photonic integrated circuit | Hall A | View Abstract |
TUES | 461 | Richard Kingsborough | MIT Lincoln Laboratory | 70 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Low-SWaP-C Colorimetric Detection of Vapor-Phase Chemical Threats | Hall A | View Abstract |
WED | 462 | Richard Osgood | U.S. Army DEVCOM Soldier Center | 632 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Photonic crystal fiber optic sensing of molecules with a quantum rectifying infrared metasurface | Hall A | View Abstract |
TUES | 463 | Pelagia Gouma | The Ohio State University | 346 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Respiratory Infection Single Exhale (RISE) Breath Test | Hall A | View Abstract |
WED | 464 | Tyler Romig | University of Maryland | 681 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Tuning Multiferroic van der Waals materials for SWaP Microsensor Applications | Hall A | View Abstract |
WED | 466 | Erik Emmons | U.S. Army DEVCOM Chemical Biological Center | 372 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | Waveguide-Enhanced Raman Spectroscopy for Field Detection of Threat Vapors | Hall A | View Abstract |
TUES | 467 | Jude Kelley | MIT Lincoln Laboratory | 768 | Quantum Technologies, Metamaterials, and the Future of CB Sensing | xPCR: An Ultra-Rapid and Portable Sensor for Automated Biothreat Surveillance | Hall A | View Abstract |
WED | 468 | Rachel Kelley | Defense Sciences, Inc. | 297 | Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again | Dry Deposition of Gases: Explorations of the Resistance Model and Use in HPAC | Hall A | View Abstract |
TUES | 469 | Riley Newcastle | DTRA | 315 | Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again | Re-aerosolization of hazardous materials: what goes down, can go back up again | Hall A | View Abstract |
WED | 470 | Matthew Magnuson | US Environmental Protection Agency/office of Research and Development/Center for Environmental Solutions and Emergency Response | 492 | Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again | Tactics and methods for prevention of resuspension of CBR contaminated particles | Hall A | View Abstract |
TUES | 471 | Hyunsook Jung | Agency for Defense Development | 140 | Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again | Velocity visualization flow field of liquid aerosols approaching the swatch test fabric | Hall A | View Abstract |
TUES | 472 | Hyunsook Jung | Agency for Defense Development | 141 | Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications | Chemical agent contamination analysis in the field operation-environment simulation using a 50-cm wind tunnel and hazard prediction model engine | Hall A | View Abstract |
TUES | 473 | Nicholas Paparoidamis | USAMRICD | 275 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Application of Molecular Docking and Pharmacophore Methods to Identify Potential Reactivators of Nerve Agent-Inhibited Acetylcholinesterase | Hall A | View Abstract |
WED | 474 | Kylene Kehn-Hall | Virginia Polytechnic Institute and State University | 414 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Comparative analysis of equine encephalitis viruses (EEVs), traumatic brain injuries (TBI), and organophosphorus nerve agents (OPNA) as a path to neuroprotective therapeutics | Hall A | View Abstract |
TUES | 475 | Hau Nguyen | Los Alamos National Laboratory | 630 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Conotoxin Prediction and Classification: New Features to Increase Prediction Accuracy | Hall A | View Abstract |
WED | 476 | Vivian Lin | Pacific Northwest National Laboratory | 91 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Discovery of non-canonical protein targets of fentanyl across tissues from animal models and humans using photoaffinity fentanyl probes | Hall A | View Abstract |
TUES | 477 | Victor Ogungbe | The University of Alabama in Huntsville and Biomolecular Science LLC | 286 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Early-Stage Investigation of Small Molecule Inhibitors Targeting Eastern Equine Encephalitis Virus (EEEV) and Western Equine Encephalitis Virus (WEEV) non-structural protein 2 (nsP2) Protease. | Hall A | View Abstract |
WED | 478 | Sayak Mukherjee | Battelle | 563 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | In Silico Discovery and Optimization Tool for Peptide Discovery for Traumatic Brain Injury Therapeutics | Hall A | View Abstract |
TUES | 479 | Liduo YIn | Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University | 202 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Machine Learning Identifies Genes Linked to Neurological Disorders | Hall A | View Abstract |
TUES | 481 | Jerome Anthony Alvarez | US Naval Research Laboratory | 41 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | TEMPRO: Nanobody Melting Temperature Estimation Model using Protein Embeddings | Hall A | View Abstract |
WED | 482 | Phillip Davis | MRIGlobal | 677 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Predictive genotype-to-phenotype modeling and applications in antivirals | Hall A | View Abstract |
TUES | 483 | Johannes Schöneberg | University of California, San Diego | 748 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Self-supervised deep learning uncovers the semantic landscape of latent mitochondrial phenotypes in human organoids to reshape the future of drug development and diagnostics | Hall A | View Abstract |
WED | 484 | Nathaniel Stemmler | SRC Inc. | 494 | Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development | Toxicity Read-Across Tools in CLEARR for Assessment of Emerging Threat Chemicals | Hall A | View Abstract |
TUES | 485 | Allen Duplantier | Latham BioPharm Group | 128 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | A structure-based drug design approach towards the discovery and lead optimization of inhibitors of alphavirus nsP2 helicase | Hall A | View Abstract |
WED | 486 | Andy Eller | Teledyne FLIR Defense | 708 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Accelerating biological research using automated high-throughput two-dimensional tandem mass spectrometry | Hall A | View Abstract |
TUES | 487 | Methun Kamruzzaman | Sandia National Labs | 737 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Accelerating Drug Discovery and Repurposing with MIRA: A Machine Learning and GenAI Approach | Hall A | View Abstract |
WED | 488 | Corie Ralston | LBNL | 382 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | An integrated structural biology platform for rapid discovery and development of diagnostics and therapeutics | Hall A | View Abstract |
WED | 489 | Zhiyuan Huang | Lawrence Berkeley National Lab | 487 | Threat Agent Defeat Modeling and Testing using WMD Simulants | A plug & play platform for peptoid-nanoparticle conjugates tuned for chemical and biological warfare agent detection and mitigation | Hall A | View Abstract |
TUES | 491 | James J. Collins | MIT | 271 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Deep learning-guided discovery and structural validation of marine toxin inhibitors | Hall A | View Abstract |
WED | 492 | Stephen Hummel | U.S. Army - West Point | 73 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Development of a ML / AI Model for Oligonucleotide Design for Respiratory Viruses | Hall A | View Abstract |
TUES | 493 | Pei Zhou | Duke University | 48 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Development of a Potent LpxC Inhibitor from Structural Insights and Machine Learning Analysis for Post-Exposure Prophylaxis Treatment of Antibiotic-Resistant Burkholderia pseudomallei in a Murine Infection Model | Hall A | View Abstract |
WED | 494 | Mariavictoria Moreno | Southwest Research Institute | 651 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Discovery and development of filovirus inhibitors: Managing off-target risk of sodium channel block with pharmacophore modeling | Hall A | View Abstract |
TUES | 495 | Bradley Kearney | National Defense Medical College / US Army Japan ESEP | 88 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Discovery of novel small-molecule compounds targeting the immune homeostasis protein TIPE2 using machine learning and high performance computing | Hall A | View Abstract |
WED | 496 | Tamir Gonen | UCLA | 16 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Disruptive Technology to Design Broad-Spectrum Countermeasures and Vaccines | Hall A | View Abstract |
TUES | 497 | Laura Dunphy | JHU/APL | 653 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Fung-AI: AI/ML-driven antifungal discovery | Hall A | View Abstract |
WED | 498 | Szczepan Baran | VeriSIM Life, Inc | 413 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Implementing AI-driven approaches for development of the target-specific compounds with high affinity as an effective countermeasure against chemical threats | Hall A | View Abstract |
TUES | 499 | Janice Chambers | Mississippi State University | 305 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | In silico identification of potential oxime antidotes to organophosphate poisoning based on a platform of novel therapeutic substituted phenoxyalkyl pyridinium oximes | Hall A | View Abstract |
WED | 500 | Lauire Kilpatrick | Temple University | 74 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | In Silico Modeling to Repurpose FDA-Approved Drugs for Treating Sepsis | Hall A | View Abstract |
TUES | 501 | James Omichinski | Université de Montréal | 406 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Leveraging AI and experimental approaches to identify Short Linear interacting Motifs (SLiMs) for antiviral therapeutics | Hall A | View Abstract |
WED | 502 | Le Thanh Mai Pham | Sandia National Laboratories | 135 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | A Machine learning model predicts antibody-virus interactions and identifies existing antibodies that neutralize emerging viral threats | Hall A | View Abstract |
TUES | 503 | Noah Winters | Battelle | 57 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Machine learning models to identify egg-adaptive mutations for rapid vaccine virus development | Hall A | View Abstract |
WED | 504 | Tyler Backman | Lawrence Berkeley National Lab | 319 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Next generation synthesis of therapeutic drugs through computational design and embedded experimental validation | Hall A | View Abstract |
TUES | 505 | Colby Ford | Center for Computational Intelligence to Predict Health and Environmental Risks; The University of North Carolina at Charlotte | 104 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Rapid and flexible development of medical countermeasures with computational structural biology and artificial intelligence | Hall A | View Abstract |
WED | 506 | Justin Reese | Lawrence Berkeley National Laboratory | 686 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | RNA-targeted AI/ML Drug Repurposing Pipeline for Aerospace Medicine | Hall A | View Abstract |
TUES | 507 | Steven Bradfute | University of New Mexico Health Sciences Center | 623 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Fiber-optic metasurface-coupled quantum rectifying sensing system | Hall A | View Abstract |
WED | 508 | Richelle Ntumy | United States Military Academy | 746 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Tailoring Oligonucleotide Lengths: Optimizing the Binding Specificity and Affinity for Target Respiratory Viruses | Hall A | View Abstract |
WED | 510 | Helen Yu | MachinaMinds | 367 | The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats | Geometric Deep Learning for Structure-Based Ligand Design | Hall A | View Abstract |
TUES | 511 | Kevin Hommema | Battelle | 50 | Threat Agent Defeat Modeling and Testing using WMD Simulants | A singular test capability for the measurement of environmental persistence of biological threats and simulants in aerosol and on surfaces | Hall A | View Abstract |
TUES | 512 | Kevin Hommema | Battelle | 720 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Flexible and Complementary Operationally Realistic Biodefense Testing | Hall A | View Abstract |
TUES | 513 | Brenton Packer | U.S. Army DEVCOM Chemical Biological Center | 604 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Aerosol generation and aerosol particle correlations on trials conducted with Sono-Tek Ultrasonic Nozzle in Joint Ambient Breeze Tunnel | Hall A | View Abstract |
WED | 514 | Vasanthi Sivaprakasam | Naval Research Laboratory | 514 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Ambient Air Test Facility for testing of Chemical Aerosol Identification Point Detection Sensors | Hall A | View Abstract |
TUES | 515 | Brad Heater | Battelle Memorial Institute | 150 | Threat Agent Defeat Modeling and Testing using WMD Simulants | CRISPR-Cas9-mediated barcode insertion into Bacillus thuringiensis for surrogate tracking | Hall A | View Abstract |
WED | 516 | Kenneth Manning | Naval Surface Warfare Center Indian Head | 292 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Development of a System to Comprehensively Characterize Gas Forming Reaction Threats | Hall A | View Abstract |
TUES | 517 | Wednesday Smith | USAMRICD | 356 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Development of Assays for Novel Reactivators of Organophosphorus-Inhibited Human Acetylcholinesterase | Hall A | View Abstract |
WED | 518 | John Cort | Pacific Northwest National Laboratory | 238 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Identification and validation of protein-chemical threat interactions from activity-based protein profiling (ABPP) data | Hall A | View Abstract |
TUES | 519 | Sun McMasters | DHS S&T CSAC | 127 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Jack Rabbit III: Environmental Factors Affecting Ammonia Airborne Plume Transport & Dispersion | Hall A | View Abstract |
WED | 520 | Carl Fossum | Virginia Tech | 682 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Mechanistic diversity and the role of water in the hydrolysis of sarin by single transition metal atoms on Mof-808 | Hall A | View Abstract |
TUES | 521 | Leena A. Nylander-French | University of North Carolina, Gillings School of Global Public Health | 620 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Model Predictions of MeS Skin Exposure Informed by the Variability of Metabolite Urinary Excretion in Controlled Human Exposures | Hall A | View Abstract |
TUES | 522 | Leena A. Nylander-French | University of North Carolina, Gillings School of Global Public Health | 622 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Development of a skin dosing method using Methyl Salicylate | Hall A | View Abstract |
WED | 524 | Bryan Tienes | NSWC Indian Head Division | 159 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Naval Surface Warfare Center Indian Head Division support to outdoor chemical simulant and biological surrogate releases in littoral and maritime environments. | Hall A | View Abstract |
TUES | 525 | Robert F Williams | Los Alamos National Laboratory | 738 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Nuclear Magnetic Resonance at Low Magnetic Fields for Signature Detection of Chemical Warfare Agents (CWAs) and Emerging Threats | Hall A | View Abstract |
WED | 526 | Inge Corbin | DTRA RD-TS Test and Assessment Division/Leidos, Inc. | 689 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Physical property review and assessment of diisopropyl methylphosphonate (DIMP) | Hall A | View Abstract |
TUES | 527 | Francis Damico | US Army, DEVCOM Chemical Biological Center | 595 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Portable Testbed for Bioaerosol Detector Performance Evaluation | Hall A | View Abstract |
TUES | 529 | Hergen Eilers | Washington State University | 49 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Materials Science in Extreme Environments University Research Alliance (MSEE URA) | Hall A | View Abstract |
TUES | 530 | Hergen Eilers | Washington State University | 266 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Materials Science in Extreme Environments University Research Alliance (MSEE URA) | Hall A | View Abstract |
WED | 532 | Steve Hanna | Hanna Consultants | 124 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Steps after Jack Rabbit II Chlorine Field Experiment to Calibrate and Post-Process Concentration and Meteorological Observations Provided by DPG | Hall A | View Abstract |
TUES | 533 | Tom Spicer | University of Arkansas | 93 | Threat Agent Defeat Modeling and Testing using WMD Simulants | Two-dimensional Particle Image Velocimetry measurements in a wind tunnel model of the Jack Rabbit II chlorine field tests | Hall A | View Abstract |
WED | 534 | Cynthia Van Acker | USAMRICD | 343 | Threat Agent Defeat Modeling and Testing using WMD Simulants - Session Chair: Bruce Hinds | Developing an Assay to Further Elucidate the Interactions of Chemical Warfare Agents and Reactivators with Acetylcholinesterase | Hall A | View Abstract |
TUES | 535 | Emily Luteran | Los Alamos National Laboratory | 212 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | A method for simultaneous evaluation of blood brain barrier transport and therapeutic functionality in vitro | Hall A | View Abstract |
WED | 536 | Julian Chen | Los Alamos National Laboratory | 691 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Aging of acetylcholinesterase, the movie: Understanding the mechanisms of dealkylation of organophosphorus-acetylcholinesterase adducts as a means of developing new medical countermeasures | Hall A | View Abstract |
WED | 538 | Paul Peterson | Los Alamos National Laboratory | 509 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Development and Implementation of Biomimetic Shuttles that Transport Charged Oximes Across the Blood Brain Barrier While Maintaining Their Therapeutic Potential | Hall A | View Abstract |
TUES | 539 | Masahiro Nakashima | National Defense Medical College | 194 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Development of a humanized mouse model to evaluate medical countermeasures of Staphylococcus aureus enterotoxin B | Hall A | View Abstract |
WED | 540 | Zoe Vaugh | Oak Ridge Institute for Science and Education | 302 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Development of a Structure-Activity Relationship of Non-Oxime Based Reactivators for Nerve Agent-Inhibited Acetylcholinesterase | Hall A | View Abstract |
WED | 542 | Nicola Wade | University of Glasgow | 387 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Discovery of medical countermeasures against α-conotoxins using a mRNA cyclic peptide display platform | Hall A | View Abstract |
TUES | 543 | Michael Capper | University of Glasgow | 106 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Elucidating the precise mechanism of ⍺-Conotoxin antagonism at the muscle-type nicotinic acetylcholine receptor | Hall A | View Abstract |
WED | 544 | HongSeok Choi | ABION Inc., Seoul 08394, Republic of Korea / Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University | 289 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Evaluation of staphylococcal enterotoxin B subunit vaccine; assessment of vaccine efficacy and residual toxicity | Hall A | View Abstract |
TUES | 545 | Larry Zana MS | Consegna Pharma Inc. | 672 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Evaluation of the Ability to Prevent Renarcotization After Carfentanil Challenge in Canines | Hall A | View Abstract |
WED | 546 | Steven Turner | University of Southampton | 313 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Investigating a possible disulfide shuffling mechanism of alpha-conotoxins using QM/MM molecular dynamics simulation. | Hall A | View Abstract |
TUES | 547 | Elizabeth Clarke | Los Alamos National Laboratory | 364 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Optimization of production and purification of nicotinic acetylcholine receptors (nAChRs) for toxin-binding analysis | Hall A | View Abstract |
WED | 548 | Melody Zacharko | U.S. Army DEVCOM Chemical Biological Center | 206 | Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure | Testing and Evaluation of Synthesized Peptide Proteins using Quality Metrics | Hall A | View Abstract |